| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 5.48e-07 | 9 | 165 | 4 | GO:0010854 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.98e-07 | 118 | 165 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH10 MYH11 MYO5B CENPE DHX40 TWNK DDX5 UBA7 SMC3 MYH14 ATP2C2 ENTPD2 MYO1F HLTF MACF1 ATP1B1 DDX41 DNAH6 | 3.46e-06 | 614 | 165 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | adenylate cyclase activator activity | 5.47e-06 | 5 | 165 | 3 | GO:0010856 | |
| GeneOntologyMolecularFunction | type 3 metabotropic glutamate receptor binding | 1.09e-05 | 6 | 165 | 3 | GO:0031800 | |
| GeneOntologyMolecularFunction | cyclase regulator activity | 1.26e-05 | 18 | 165 | 4 | GO:0010851 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.46e-05 | 38 | 165 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 6.37e-05 | 10 | 165 | 3 | GO:0030235 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.17e-04 | 227 | 165 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | cyclase activator activity | 1.49e-04 | 13 | 165 | 3 | GO:0010853 | |
| GeneOntologyMolecularFunction | titin binding | 1.89e-04 | 14 | 165 | 3 | GO:0031432 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor binding | 2.87e-04 | 16 | 165 | 3 | GO:0035256 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 2.87e-04 | 16 | 165 | 3 | GO:0008179 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | VIL1 RALA DCDC2 MYH10 MYH11 CALM1 CALM2 MYO5B CENPE CALM3 TRIOBP ADGRV1 SMC3 MYH14 ENAH MYO1F MACF1 FERMT2 USH2A UTRN KLC1 | 2.93e-04 | 1099 | 165 | 21 | GO:0008092 |
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 3.46e-04 | 17 | 165 | 3 | GO:0072542 | |
| GeneOntologyMolecularFunction | epidermal growth factor receptor activity | 4.03e-04 | 4 | 165 | 2 | GO:0005006 | |
| GeneOntologyMolecularFunction | calcium ion binding | VIL1 EFCAB6 CALM1 CALM2 CALM3 EFEMP2 PCDHB13 ADGRV1 CUBN PPEF2 PPEF1 FBN1 EFEMP1 CELSR2 MACF1 CDH5 | 4.93e-04 | 749 | 165 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | glutamate receptor binding | 5.60e-04 | 81 | 165 | 5 | GO:0035254 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 5.70e-04 | 20 | 165 | 3 | GO:0019211 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ENTPD7 RALA RALB MYO5B DHX40 TWNK DDX5 PLPP1 SMC3 ATP2C2 ENTPD2 HLTF MACF1 RASL11B DDX41 DNAH6 AGAP2 | 6.05e-04 | 840 | 165 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ENTPD7 RALA RALB MYO5B DHX40 TWNK DDX5 PLPP1 SMC3 ATP2C2 ENTPD2 HLTF MACF1 RASL11B DDX41 DNAH6 AGAP2 | 6.05e-04 | 840 | 165 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | calmodulin binding | 6.69e-04 | 230 | 165 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 7.60e-04 | 22 | 165 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | DSP RPS2 GLOD4 MMP24 FBN1 PTPRD TENM1 MACF1 FERMT2 UTRN CDH5 TNXB JAM3 | 1.45e-03 | 599 | 165 | 13 | GO:0050839 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ENTPD7 RALA RALB MYO5B DHX40 TWNK DDX5 PLPP1 SMC3 ATP2C2 ENTPD2 MACF1 RASL11B DDX41 DNAH6 AGAP2 | 1.62e-03 | 839 | 165 | 16 | GO:0016462 |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.78e-03 | 268 | 165 | 8 | GO:0005539 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ENTPD7 RALA RALB MYO5B DHX40 TWNK DDX5 SMC3 ATP2C2 ENTPD2 MACF1 RASL11B DDX41 DNAH6 AGAP2 | 1.97e-03 | 775 | 165 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | actin binding | VIL1 MYH10 MYH11 MYO5B TRIOBP MYH14 ENAH MYO1F MACF1 FERMT2 UTRN | 2.17e-03 | 479 | 165 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | UDP phosphatase activity | 2.35e-03 | 9 | 165 | 2 | GO:0045134 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclic-nucleotide phosphodiesterase activity | 4.76e-07 | 3 | 162 | 3 | GO:0051343 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion export across plasma membrane | 4.70e-06 | 5 | 162 | 3 | GO:1905913 | |
| GeneOntologyBiologicalProcess | regulation of cyclic-nucleotide phosphodiesterase activity | 9.35e-06 | 6 | 162 | 3 | GO:0051342 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion export across plasma membrane | 9.35e-06 | 6 | 162 | 3 | GO:1905912 | |
| GeneOntologyBiologicalProcess | mammary gland alveolus development | 2.40e-05 | 22 | 162 | 4 | GO:0060749 | |
| GeneOntologyBiologicalProcess | mammary gland lobule development | 2.40e-05 | 22 | 162 | 4 | GO:0061377 | |
| GeneOntologyBiologicalProcess | negative regulation of high voltage-gated calcium channel activity | 2.59e-05 | 8 | 162 | 3 | GO:1901842 | |
| GeneOntologyBiologicalProcess | action potential | 3.10e-05 | 201 | 162 | 9 | GO:0001508 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | RALB DDR1 ERBB4 CALM1 CALM2 CENPE CALM3 RPS2 MAGI3 APOA1 FBN1 TENM1 FERMT2 AGAP2 | 3.39e-05 | 490 | 162 | 14 | GO:0051347 |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-threonine phosphorylation | 3.45e-05 | 24 | 162 | 4 | GO:0010801 | |
| GeneOntologyBiologicalProcess | protein dephosphorylation | CALM1 CALM2 CALM3 DUSP1 SLC39A10 PPEF2 PPEF1 PTPRD ACP4 CDH5 | 3.61e-05 | 256 | 162 | 10 | GO:0006470 |
| GeneOntologyBiologicalProcess | positive regulation of ryanodine-sensitive calcium-release channel activity | 3.86e-05 | 9 | 162 | 3 | GO:0060316 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling involved in cardiac conduction | 4.79e-05 | 26 | 162 | 4 | GO:0086064 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 6.39e-05 | 87 | 162 | 6 | GO:0086001 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by calcium ion signaling | 6.48e-05 | 28 | 162 | 4 | GO:0010882 | |
| GeneOntologyBiologicalProcess | regulation of transferase activity | RALB DDR1 ERBB4 CALM1 CALM2 CENPE CALM3 RPS2 DUSP1 MAGI3 APOA1 PPEF2 FBN1 TENM1 ACP4 FERMT2 TNXB AGAP2 | 7.03e-05 | 810 | 162 | 18 | GO:0051338 |
| GeneOntologyBiologicalProcess | elastic fiber assembly | 7.49e-05 | 11 | 162 | 3 | GO:0048251 | |
| GeneOntologyBiologicalProcess | negative regulation of ryanodine-sensitive calcium-release channel activity | 7.49e-05 | 11 | 162 | 3 | GO:0060315 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 8.57e-05 | 30 | 162 | 4 | GO:0098901 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | RALB DDR1 ERBB4 CALM1 CALM2 CENPE CALM3 MAGI3 FBN1 TENM1 FERMT2 AGAP2 | 8.89e-05 | 405 | 162 | 12 | GO:0033674 |
| GeneOntologyBiologicalProcess | dephosphorylation | CALM1 CALM2 CALM3 DUSP1 SLC39A10 PPEF2 PPEF1 PTPRD PLPP1 ACP4 CDH5 | 9.72e-05 | 347 | 162 | 11 | GO:0016311 |
| GeneOntologyBiologicalProcess | positive regulation of phosphatase activity | 9.78e-05 | 31 | 162 | 4 | GO:0010922 | |
| GeneOntologyBiologicalProcess | calcium ion export across plasma membrane | 9.93e-05 | 12 | 162 | 3 | GO:1990034 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling involved in cardiac conduction | 9.93e-05 | 12 | 162 | 3 | GO:1901844 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 9.99e-05 | 59 | 162 | 5 | GO:0086065 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | RALB DDR1 ERBB4 CALM1 CALM2 CENPE CALM3 DUSP1 MAGI3 PPEF2 FBN1 TENM1 ACP4 FERMT2 TNXB AGAP2 | 1.04e-04 | 686 | 162 | 16 | GO:0043549 |
| GeneOntologyBiologicalProcess | positive regulation of dephosphorylation | 1.27e-04 | 62 | 162 | 5 | GO:0035306 | |
| GeneOntologyBiologicalProcess | detection of calcium ion | 1.28e-04 | 13 | 162 | 3 | GO:0005513 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling | 1.59e-04 | 35 | 162 | 4 | GO:0010644 | |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 1.71e-04 | 148 | 162 | 7 | GO:1902414 | |
| GeneOntologyBiologicalProcess | positive regulation of aortic smooth muscle cell differentiation | 1.83e-04 | 3 | 162 | 2 | GO:1904831 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 1.94e-04 | 151 | 162 | 7 | GO:0045727 | |
| GeneOntologyBiologicalProcess | positive regulation of transporter activity | 2.01e-04 | 107 | 162 | 6 | GO:0032411 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transporter activity | 2.43e-04 | 39 | 162 | 4 | GO:1901021 | |
| GeneOntologyBiologicalProcess | regulation of high voltage-gated calcium channel activity | 2.47e-04 | 16 | 162 | 3 | GO:1901841 | |
| GeneOntologyBiologicalProcess | negative regulation of release of sequestered calcium ion into cytosol | 2.98e-04 | 17 | 162 | 3 | GO:0051280 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 3.26e-04 | 217 | 162 | 8 | GO:0006941 | |
| GeneOntologyBiologicalProcess | muscle contraction | MYH11 TPCN2 CALM1 CALM2 CALM3 DSP CHUK MYH14 SCN1A ATP1B1 UTRN | 3.33e-04 | 400 | 162 | 11 | GO:0006936 |
| GeneOntologyBiologicalProcess | regulation of protein kinase activity | RALB CALM1 CALM2 CENPE CALM3 DUSP1 MAGI3 PPEF2 FBN1 TENM1 ACP4 FERMT2 TNXB AGAP2 | 3.41e-04 | 611 | 162 | 14 | GO:0045859 |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling | 3.56e-04 | 18 | 162 | 3 | GO:0010649 | |
| GeneOntologyBiologicalProcess | positive regulation of collagen fibril organization | 3.64e-04 | 4 | 162 | 2 | GO:1904028 | |
| GeneOntologyBiologicalProcess | regulation of aortic smooth muscle cell differentiation | 3.64e-04 | 4 | 162 | 2 | GO:1904829 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | CBLL1 DDR1 DUSP1 PIEZO1 EFEMP2 TRIOBP APOA1 GLMN CELSR2 MIP DHPS MYO1F MACF1 FERMT2 UTRN TNXB VAV1 JAM3 | 3.71e-04 | 927 | 162 | 18 | GO:0030155 |
| GeneOntologyBiologicalProcess | positive regulation of sequestering of calcium ion | 4.20e-04 | 19 | 162 | 3 | GO:0051284 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | RALB ERBB4 CALM1 CALM2 CENPE CALM3 YBX1 RPS2 RPS4X MAGI3 NR1H3 YBX3 UPF3B SLC39A10 NGRN HABP4 FBN1 ASB5 UHMK1 TENM1 FERMT2 CTSD CDH5 AGAP2 | 4.47e-04 | 1458 | 162 | 24 | GO:0051247 |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 4.61e-04 | 350 | 162 | 10 | GO:0045860 | |
| GeneOntologyBiologicalProcess | regulation of integrin activation | 4.91e-04 | 20 | 162 | 3 | GO:0033623 | |
| GeneOntologyBiologicalProcess | mammary gland epithelium development | 5.26e-04 | 84 | 162 | 5 | GO:0061180 | |
| GeneOntologyBiologicalProcess | regulation of protein serine/threonine kinase activity | 5.50e-04 | 358 | 162 | 10 | GO:0071900 | |
| GeneOntologyBiologicalProcess | negative regulation of voltage-gated calcium channel activity | 5.70e-04 | 21 | 162 | 3 | GO:1901386 | |
| GeneOntologyBiologicalProcess | maintenance of animal organ identity | 6.04e-04 | 5 | 162 | 2 | GO:0048496 | |
| GeneOntologyBiologicalProcess | regulation of transporter activity | 6.12e-04 | 299 | 162 | 9 | GO:0032409 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | ENTPD7 ERBB4 NEIL1 LPCAT4 MAGI3 NR1H3 APOA1 PFKFB4 SH3YL1 TKFC PLPP1 LACC1 UCP2 ENTPD2 ATP1B1 MBD4 GPAT2 TNXB SDHA AGAP2 | 6.49e-04 | 1142 | 162 | 20 | GO:0019637 |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 6.56e-04 | 22 | 162 | 3 | GO:0010881 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction | 6.86e-04 | 89 | 162 | 5 | GO:0055117 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-threonine phosphorylation | 7.40e-04 | 52 | 162 | 4 | GO:0010799 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide catabolic process | 7.50e-04 | 23 | 162 | 3 | GO:0006244 | |
| GeneOntologyBiologicalProcess | export across plasma membrane | 7.58e-04 | 91 | 162 | 5 | GO:0140115 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | RALB DDR1 ERBB4 CALM1 CALM2 CENPE CALM3 RPS2 PDZK1 MAGI3 NR1H3 APOA1 SLC39A10 CHUK FBN1 TENM1 CTH PLCL1 ATP1B1 FERMT2 CTSD VAV1 AGAP2 | 8.15e-04 | 1430 | 162 | 23 | GO:0044093 |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | 8.48e-04 | 193 | 162 | 7 | GO:0071902 | |
| GeneOntologyBiologicalProcess | actin filament-based process | VIL1 RALA MYH10 MYH11 MYO5B DSP TRIOBP APOA1 MYH14 SCN1A ENAH MYO1F TENM1 FERMT2 TNXB JAM3 AGAP2 | 8.54e-04 | 912 | 162 | 17 | GO:0030029 |
| GeneOntologyBiologicalProcess | aortic smooth muscle cell differentiation | 9.01e-04 | 6 | 162 | 2 | GO:0035887 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transporter activity | 9.65e-04 | 256 | 162 | 8 | GO:0032412 | |
| GeneOntologyBiologicalProcess | positive regulation of ion transmembrane transporter activity | 1.01e-03 | 97 | 162 | 5 | GO:0032414 | |
| GeneOntologyBiologicalProcess | mRNA transcription | 1.05e-03 | 57 | 162 | 4 | GO:0009299 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | VIL1 DDR1 DCDC2 MYH10 MYH11 MYO5B PDZK1 TRIOBP ADGRV1 CUBN LCT MYH14 USH2A | 2.80e-08 | 223 | 166 | 13 | GO:0098862 |
| GeneOntologyCellularComponent | brush border | 3.59e-06 | 152 | 166 | 9 | GO:0005903 | |
| GeneOntologyCellularComponent | extracellular matrix | EFEMP2 COL6A5 APOA1 MUC5B MMP24 FBN1 EFEMP1 SMC3 ENTPD2 CST4 HAPLN3 SERPINC1 PCOLCE2 GPC2 MMP15 CTSD USH2A TNXB | 5.03e-06 | 656 | 166 | 18 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | EFEMP2 COL6A5 APOA1 MUC5B MMP24 FBN1 EFEMP1 SMC3 ENTPD2 CST4 HAPLN3 SERPINC1 PCOLCE2 GPC2 MMP15 CTSD USH2A TNXB | 5.24e-06 | 658 | 166 | 18 | GO:0030312 |
| GeneOntologyCellularComponent | myelin sheath | 9.59e-06 | 217 | 166 | 10 | GO:0043209 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | EFEMP2 COL6A5 APOA1 FBN1 EFEMP1 SMC3 ENTPD2 CST4 HAPLN3 SERPINC1 PCOLCE2 GPC2 CTSD USH2A TNXB | 2.25e-05 | 530 | 166 | 15 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 5.46e-05 | 122 | 166 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | supramolecular fiber | DCDC2 MYH10 MYH11 EFCAB6 CALM1 CALM2 CENPE CALM3 DSP EFEMP2 DCDC2B HABP4 FBN1 MYH14 SCN1A MYO1F CST4 SCO1 MACF1 FERMT2 DNAH6 JAM3 KLC1 | 6.03e-05 | 1179 | 166 | 23 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | DCDC2 MYH10 MYH11 EFCAB6 CALM1 CALM2 CENPE CALM3 DSP EFEMP2 DCDC2B HABP4 FBN1 MYH14 SCN1A MYO1F CST4 SCO1 MACF1 FERMT2 DNAH6 JAM3 KLC1 | 6.68e-05 | 1187 | 166 | 23 | GO:0099081 |
| GeneOntologyCellularComponent | actin-based cell projection | 7.92e-05 | 278 | 166 | 10 | GO:0098858 | |
| GeneOntologyCellularComponent | myosin complex | 1.05e-04 | 59 | 166 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | cell projection membrane | PSD2 PIEZO1 PDZK1 IFIT5 ADGRV1 CUBN SH3YL1 ENTPD2 MACF1 FERMT2 USH2A UTRN | 1.77e-04 | 431 | 166 | 12 | GO:0031253 |
| GeneOntologyCellularComponent | myosin II filament | 1.87e-04 | 3 | 166 | 2 | GO:0097513 | |
| GeneOntologyCellularComponent | leading edge membrane | 2.82e-04 | 210 | 166 | 8 | GO:0031256 | |
| GeneOntologyCellularComponent | actin filament bundle | 3.63e-04 | 118 | 166 | 6 | GO:0032432 | |
| GeneOntologyCellularComponent | USH2 complex | 3.72e-04 | 4 | 166 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 5.33e-04 | 290 | 166 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 6.47e-04 | 238 | 166 | 8 | GO:0097729 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 9.21e-04 | 6 | 166 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 9.21e-04 | 6 | 166 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilium membrane | 9.21e-04 | 6 | 166 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 9.21e-04 | 6 | 166 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | myosin filament | 9.95e-04 | 25 | 166 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 1.39e-03 | 28 | 166 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 1.65e-03 | 107 | 166 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 1.65e-03 | 107 | 166 | 5 | GO:0001725 | |
| GeneOntologyCellularComponent | sperm midpiece | 1.68e-03 | 64 | 166 | 4 | GO:0097225 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 1.70e-03 | 8 | 166 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | IkappaB kinase complex | 1.70e-03 | 8 | 166 | 2 | GO:0008385 | |
| GeneOntologyCellularComponent | anchoring junction | RALA DSP RPS2 RPS4X CNTNAP1 TRIOBP MAGI3 YBX3 PDIA3 SCN1A ENAH MIP ATP1B1 FERMT2 CDH5 VAV1 JAM3 | 2.00e-03 | 976 | 166 | 17 | GO:0070161 |
| GeneOntologyCellularComponent | RNA N6-methyladenosine methyltransferase complex | 2.18e-03 | 9 | 166 | 2 | GO:0036396 | |
| GeneOntologyCellularComponent | cell leading edge | VIL1 MYH10 PSD2 PIEZO1 IFIT5 ADGRV1 SH3YL1 ENAH MACF1 FERMT2 USH2A | 2.23e-03 | 500 | 166 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | actin cytoskeleton | VIL1 MYH10 MYH11 MYO5B TRIOBP IFIT5 MYH14 ENAH MYO1F MACF1 FERMT2 JAM3 | 2.23e-03 | 576 | 166 | 12 | GO:0015629 |
| GeneOntologyCellularComponent | nuclear speck | 2.40e-03 | 431 | 166 | 10 | GO:0016607 | |
| GeneOntologyCellularComponent | actomyosin | 2.44e-03 | 117 | 166 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.73e-03 | 73 | 166 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | calyx of Held | 2.90e-03 | 36 | 166 | 3 | GO:0044305 | |
| GeneOntologyCellularComponent | microvillus | 3.03e-03 | 123 | 166 | 5 | GO:0005902 | |
| GeneOntologyCellularComponent | paranodal junction | 3.29e-03 | 11 | 166 | 2 | GO:0033010 | |
| GeneOntologyCellularComponent | stereocilium bundle | 3.63e-03 | 79 | 166 | 4 | GO:0032421 | |
| Domain | IQ | 2.08e-07 | 71 | 165 | 8 | PF00612 | |
| Domain | IQ | 5.82e-07 | 81 | 165 | 8 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 1.31e-06 | 90 | 165 | 8 | IPR000048 | |
| Domain | IQ | 1.69e-06 | 93 | 165 | 8 | PS50096 | |
| Domain | Myosin_S1_N | 6.68e-06 | 5 | 165 | 3 | IPR008989 | |
| Domain | COLD_SHOCK | 1.33e-05 | 6 | 165 | 3 | PS00352 | |
| Domain | Cold-shock_CS | 1.33e-05 | 6 | 165 | 3 | IPR019844 | |
| Domain | Myosin_head_motor_dom | 2.01e-05 | 38 | 165 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.01e-05 | 38 | 165 | 5 | PS51456 | |
| Domain | Myosin_head | 2.01e-05 | 38 | 165 | 5 | PF00063 | |
| Domain | MYSc | 2.01e-05 | 38 | 165 | 5 | SM00242 | |
| Domain | CSP | 3.67e-05 | 8 | 165 | 3 | SM00357 | |
| Domain | Cold_shock_prot | 3.67e-05 | 8 | 165 | 3 | IPR011129 | |
| Domain | CSD | 3.67e-05 | 8 | 165 | 3 | PF00313 | |
| Domain | CSP_DNA-bd | 3.67e-05 | 8 | 165 | 3 | IPR002059 | |
| Domain | P-loop_NTPase | RALA RALB MYH10 MYH11 MYO5B CENPE DHX40 MAGI3 TWNK PFKFB4 DDX5 SBNO1 SMC3 MYH14 MYO1F HLTF RASL11B DDX41 DNAH6 AGAP2 | 6.10e-05 | 848 | 165 | 20 | IPR027417 |
| Domain | Ral | 7.76e-05 | 2 | 165 | 2 | IPR028412 | |
| Domain | Ser/Thr-Pase_EF-hand_contain | 7.76e-05 | 2 | 165 | 2 | IPR012008 | |
| Domain | - | 1.97e-04 | 95 | 165 | 6 | 2.60.120.200 | |
| Domain | EF-hand-dom_pair | EFCAB6 CALM1 CALM3 LPCAT4 PPEF2 PPEF1 SCN1A MACF1 PLCL1 UTRN | 2.42e-04 | 287 | 165 | 10 | IPR011992 |
| Domain | Myosin_N | 2.85e-04 | 15 | 165 | 3 | PF02736 | |
| Domain | Myosin_N | 2.85e-04 | 15 | 165 | 3 | IPR004009 | |
| Domain | EGF_1 | 4.51e-04 | 255 | 165 | 9 | PS00022 | |
| Domain | PPP5 | 4.60e-04 | 4 | 165 | 2 | PF08321 | |
| Domain | PPP_dom | 4.60e-04 | 4 | 165 | 2 | IPR013235 | |
| Domain | DUF3377 | 4.60e-04 | 4 | 165 | 2 | PF11857 | |
| Domain | Pept_M10A_metallopeptidase_C | 4.60e-04 | 4 | 165 | 2 | IPR021805 | |
| Domain | Growth_fac_rcpt_ | 4.78e-04 | 156 | 165 | 7 | IPR009030 | |
| Domain | Myosin_tail_1 | 5.01e-04 | 18 | 165 | 3 | PF01576 | |
| Domain | Myosin_tail | 5.01e-04 | 18 | 165 | 3 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 5.91e-04 | 19 | 165 | 3 | IPR027401 | |
| Domain | - | 5.91e-04 | 19 | 165 | 3 | 4.10.270.10 | |
| Domain | DUF4704 | 7.62e-04 | 5 | 165 | 2 | IPR031570 | |
| Domain | DUF4704 | 7.62e-04 | 5 | 165 | 2 | PF15787 | |
| Domain | CUB | 9.13e-04 | 49 | 165 | 4 | PF00431 | |
| Domain | CUB | 9.86e-04 | 50 | 165 | 4 | SM00042 | |
| Domain | - | 1.14e-03 | 6 | 165 | 2 | 3.90.1290.10 | |
| Domain | DCX | 1.14e-03 | 6 | 165 | 2 | SM00537 | |
| Domain | PH_BEACH | 1.14e-03 | 6 | 165 | 2 | PF14844 | |
| Domain | TPR_10 | 1.14e-03 | 6 | 165 | 2 | PF13374 | |
| Domain | - | 1.14e-03 | 52 | 165 | 4 | 2.60.120.290 | |
| Domain | EGF | 1.18e-03 | 235 | 165 | 8 | SM00181 | |
| Domain | EGF_3 | 1.18e-03 | 235 | 165 | 8 | PS50026 | |
| Domain | CUB | 1.23e-03 | 53 | 165 | 4 | PS01180 | |
| Domain | cEGF | 1.52e-03 | 26 | 165 | 3 | PF12662 | |
| Domain | cEGF | 1.52e-03 | 26 | 165 | 3 | IPR026823 | |
| Domain | - | 1.58e-03 | 7 | 165 | 2 | 3.10.20.230 | |
| Domain | Plectin | 1.58e-03 | 7 | 165 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.58e-03 | 7 | 165 | 2 | IPR001101 | |
| Domain | DCX | 1.58e-03 | 7 | 165 | 2 | PF03607 | |
| Domain | PLEC | 1.58e-03 | 7 | 165 | 2 | SM00250 | |
| Domain | CUB_dom | 1.61e-03 | 57 | 165 | 4 | IPR000859 | |
| Domain | EGF-like_dom | 1.70e-03 | 249 | 165 | 8 | IPR000742 | |
| Domain | ASX_HYDROXYL | 1.94e-03 | 100 | 165 | 5 | PS00010 | |
| Domain | Spectrin_repeat | 2.09e-03 | 29 | 165 | 3 | IPR002017 | |
| Domain | DC | 2.10e-03 | 8 | 165 | 2 | PS50309 | |
| Domain | PH-BEACH_dom | 2.10e-03 | 8 | 165 | 2 | IPR023362 | |
| Domain | GDA1_CD39_NTPase | 2.10e-03 | 8 | 165 | 2 | IPR000407 | |
| Domain | - | 2.10e-03 | 8 | 165 | 2 | 2.30.29.40 | |
| Domain | GDA1_CD39 | 2.10e-03 | 8 | 165 | 2 | PF01150 | |
| Domain | PH_BEACH | 2.10e-03 | 8 | 165 | 2 | PS51783 | |
| Domain | GDA1_CD39_NTPASE | 2.10e-03 | 8 | 165 | 2 | PS01238 | |
| Domain | Doublecortin_dom | 2.10e-03 | 8 | 165 | 2 | IPR003533 | |
| Domain | EGF-like_CS | 2.28e-03 | 261 | 165 | 8 | IPR013032 | |
| Domain | - | 2.28e-03 | 261 | 165 | 8 | 1.10.238.10 | |
| Domain | EGF_2 | 2.50e-03 | 265 | 165 | 8 | PS01186 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.50e-03 | 106 | 165 | 5 | IPR000152 | |
| Domain | BEACH | 2.68e-03 | 9 | 165 | 2 | PS50197 | |
| Domain | Beach | 2.68e-03 | 9 | 165 | 2 | PF02138 | |
| Domain | - | 2.68e-03 | 9 | 165 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.68e-03 | 9 | 165 | 2 | SM01026 | |
| Domain | BEACH_dom | 2.68e-03 | 9 | 165 | 2 | IPR000409 | |
| Domain | SPEC | 2.78e-03 | 32 | 165 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.78e-03 | 32 | 165 | 3 | IPR018159 | |
| Domain | EFh | 2.83e-03 | 158 | 165 | 6 | SM00054 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 5.83e-08 | 23 | 134 | 6 | MM15222 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 8.28e-06 | 5 | 134 | 3 | MM14493 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 8.48e-06 | 30 | 134 | 5 | MM15170 | |
| Pathway | REACTOME_CAM_PDE_1_ACTIVATION | 1.64e-05 | 6 | 134 | 3 | MM14494 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS | 1.64e-05 | 6 | 134 | 3 | MM15662 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 2.86e-05 | 7 | 134 | 3 | MM1357 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 4.12e-05 | 21 | 134 | 4 | M27494 | |
| Pathway | REACTOME_PROTEIN_METHYLATION | 5.00e-05 | 22 | 134 | 4 | MM15519 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 6.77e-05 | 9 | 134 | 3 | M3412 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 8.46e-05 | 25 | 134 | 4 | MM1441 | |
| Pathway | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | 9.60e-05 | 10 | 134 | 3 | MM14570 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE | 9.60e-05 | 10 | 134 | 3 | M47954 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 9.92e-05 | 26 | 134 | 4 | M17941 | |
| Pathway | REACTOME_CALCINEURIN_ACTIVATES_NFAT | 1.31e-04 | 11 | 134 | 3 | MM14810 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.31e-04 | 11 | 134 | 3 | M47958 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | DDR1 EFEMP2 COL6A5 MMP24 FBN1 EFEMP1 PCOLCE2 MMP15 CTSD TNXB JAM3 | 1.36e-04 | 300 | 134 | 11 | M610 |
| Pathway | REACTOME_ENOS_ACTIVATION | 1.74e-04 | 12 | 134 | 3 | MM14817 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 1.74e-04 | 12 | 134 | 3 | MM15142 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY | 1.74e-04 | 12 | 134 | 3 | M47956 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.77e-04 | 258 | 134 | 10 | MM14572 | |
| Pathway | REACTOME_THE_PHOTOTRANSDUCTION_CASCADE | 2.01e-04 | 31 | 134 | 4 | MM14896 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.03e-04 | 57 | 134 | 5 | MM15643 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 2.24e-04 | 13 | 134 | 3 | MM15078 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 2.28e-04 | 32 | 134 | 4 | MM1355 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 2.41e-04 | 92 | 134 | 6 | MM14881 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 2.58e-04 | 33 | 134 | 4 | M9494 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 2.83e-04 | 14 | 134 | 3 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 2.83e-04 | 14 | 134 | 3 | M47388 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.83e-04 | 14 | 134 | 3 | MM15052 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 2.83e-04 | 14 | 134 | 3 | MM1473 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 2.83e-04 | 14 | 134 | 3 | MM15391 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 3.25e-04 | 35 | 134 | 4 | MM15114 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 3.51e-04 | 15 | 134 | 3 | M47385 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 3.51e-04 | 15 | 134 | 3 | MM1387 | |
| Pathway | REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION | 3.51e-04 | 15 | 134 | 3 | MM14795 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 3.51e-04 | 15 | 134 | 3 | M15181 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 3.51e-04 | 15 | 134 | 3 | MM15103 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 4.30e-04 | 16 | 134 | 3 | MM14492 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 4.30e-04 | 16 | 134 | 3 | MM1483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 4.30e-04 | 16 | 134 | 3 | M47449 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | CBLL1 UBR2 MRC1 FBXW10B CALM1 CALM2 CENPE CALM3 FBXL14 PDIA3 CHUK GLMN UBA7 ASB5 CTSD VAV1 KLC1 | 4.65e-04 | 719 | 134 | 17 | MM14540 |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 4.77e-04 | 191 | 134 | 8 | MM15586 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 4.96e-04 | 39 | 134 | 4 | MM1397 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 4.96e-04 | 39 | 134 | 4 | M1908 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 5.18e-04 | 17 | 134 | 3 | M10066 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 5.18e-04 | 17 | 134 | 3 | M47387 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 5.18e-04 | 17 | 134 | 3 | M5940 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 5.18e-04 | 17 | 134 | 3 | MM1372 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 5.18e-04 | 17 | 134 | 3 | M2349 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN | 5.18e-04 | 17 | 134 | 3 | M47560 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 6.17e-04 | 18 | 134 | 3 | MM1385 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 6.17e-04 | 18 | 134 | 3 | M47580 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 6.17e-04 | 18 | 134 | 3 | M5290 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 6.17e-04 | 18 | 134 | 3 | MM15577 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 6.17e-04 | 18 | 134 | 3 | M3430 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 6.60e-04 | 42 | 134 | 4 | MM1504 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 7.28e-04 | 19 | 134 | 3 | M27493 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 7.28e-04 | 19 | 134 | 3 | M27489 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 7.28e-04 | 19 | 134 | 3 | MM1453 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 7.28e-04 | 19 | 134 | 3 | M47543 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 7.28e-04 | 19 | 134 | 3 | M47957 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 7.89e-04 | 44 | 134 | 4 | M19784 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 8.50e-04 | 20 | 134 | 3 | M18415 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 8.50e-04 | 20 | 134 | 3 | MM1445 | |
| Pathway | REACTOME_HDL_CLEARANCE | 8.80e-04 | 5 | 134 | 2 | M27844 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 9.85e-04 | 21 | 134 | 3 | M11650 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 9.85e-04 | 21 | 134 | 3 | M47542 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.13e-03 | 271 | 134 | 9 | MM15406 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.13e-03 | 22 | 134 | 3 | MM15104 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | MYH10 MYH11 RPS2 RPS4X CNTNAP1 MAGOHB COL6A5 UPF3B ADGRV1 MYH14 SCN1A ENAH UTRN AGAP2 | 1.14e-03 | 575 | 134 | 14 | M29853 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.29e-03 | 23 | 134 | 3 | M47512 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 1.47e-03 | 24 | 134 | 3 | M2243 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.47e-03 | 24 | 134 | 3 | M47509 | |
| Pathway | KEGG_TIGHT_JUNCTION | 1.62e-03 | 132 | 134 | 6 | M11355 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 1.66e-03 | 25 | 134 | 3 | M1547 | |
| Pathway | REACTOME_METABOLISM_OF_COFACTORS | 1.66e-03 | 25 | 134 | 3 | MM15574 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.66e-03 | 25 | 134 | 3 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.66e-03 | 25 | 134 | 3 | M47511 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 1.69e-03 | 133 | 134 | 6 | MM15529 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.71e-03 | 54 | 134 | 4 | MM15202 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 1.86e-03 | 26 | 134 | 3 | MM1346 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.86e-03 | 26 | 134 | 3 | MM14495 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 1.86e-03 | 26 | 134 | 3 | MM1371 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 1.86e-03 | 26 | 134 | 3 | MM1431 | |
| Pathway | WP_RAS_SIGNALING | 1.88e-03 | 184 | 134 | 7 | M39764 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 2.08e-03 | 27 | 134 | 3 | M14899 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 2.08e-03 | 27 | 134 | 3 | M7739 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 2.08e-03 | 27 | 134 | 3 | M27422 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 2.08e-03 | 27 | 134 | 3 | MM15053 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 2.23e-03 | 58 | 134 | 4 | MM14914 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 2.31e-03 | 28 | 134 | 3 | MM14711 | |
| Pathway | BIOCARTA_NO1_PATHWAY | 2.31e-03 | 28 | 134 | 3 | M4383 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.31e-03 | 28 | 134 | 3 | M47508 | |
| Pathway | REACTOME_CLEAVAGE_OF_THE_DAMAGED_PYRIMIDINE | 2.42e-03 | 8 | 134 | 2 | MM14478 | |
| Pathway | REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS | 2.42e-03 | 8 | 134 | 2 | M27737 | |
| Pathway | REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS | 2.42e-03 | 8 | 134 | 2 | MM15486 | |
| Pathway | PID_FCER1_PATHWAY | 2.52e-03 | 60 | 134 | 4 | M7 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 2.56e-03 | 29 | 134 | 3 | MM1356 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 2.56e-03 | 29 | 134 | 3 | M13494 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 2.56e-03 | 29 | 134 | 3 | MM15219 | |
| Pubmed | 2.40e-12 | 5 | 167 | 5 | 12034722 | ||
| Pubmed | 1.44e-11 | 6 | 167 | 5 | 12051765 | ||
| Pubmed | UBR2 RBM15 MYH10 CALM2 MYO5B CALM3 DSP DUSP1 FBXL14 TRIOBP NBEA CACHD1 SLC39A10 PPEF2 TARS2 PPEF1 PDIA3 GLMN PTPRD SUPT5H ENAH DHPS CPSF1 UTRN | 2.59e-10 | 1049 | 167 | 24 | 27880917 | |
| Pubmed | VIL1 RALA RALB MYH10 MYH11 MYO5B YBX1 DSP BCLAF1 RPS4X LPCAT4 IFIT5 MAGI3 TWNK YBX3 PDIA3 DDX5 CHUK NUP205 YBX2 SPCS3 SBNO1 MYH14 ENTPD2 TENM1 MACF1 DNAH6 AGAP2 | 3.02e-10 | 1442 | 167 | 28 | 35575683 | |
| Pubmed | CALM1 DSP EFEMP2 CNTNAP1 TRIOBP IFIT5 MAGI3 SRPK2 NBEA CACHD1 CHUK SH3YL1 UBA7 FBN1 EFEMP1 PTPRD SBNO1 MYH14 SUPT5H MACF1 WDFY3 MBD4 UTRN SDHA AGAP2 | 2.91e-09 | 1285 | 167 | 25 | 35914814 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RALB MYH10 CALM1 YBX1 DSP RPS2 RPS4X RPP40 MAGOHB SRPK2 YBX3 UPF3B GLOD4 PDIA3 DDX5 TXNL1 SBNO1 SMC3 ENAH HLTF SCO1 MACF1 CTH DDX41 CTSD SDHA | 4.42e-09 | 1415 | 167 | 26 | 28515276 |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | MYH10 CALM1 CALM2 CALM3 YBX1 RPS2 BCLAF1 RPS4X SRPK2 YBX3 DDX5 CHUK SDHA | 5.22e-09 | 317 | 167 | 13 | 17620599 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYH10 MYH11 CALM1 YBX1 DSP RPS2 BCLAF1 RPS4X SRPK2 YBX3 UPF3B DDX5 YBX2 SMC3 MYH14 SCO1 MACF1 DNAH6 UTRN SDHA | 5.36e-09 | 847 | 167 | 20 | 35235311 |
| Pubmed | RALA ERBB4 MYH10 HECW1 CALM1 CALM2 YBX1 DSP RPS2 BCLAF1 RPS4X CNTNAP1 TRIOBP NBEA TXNL1 CELSR2 SCN1A ENAH TENM1 MACF1 FERMT2 SDHA AGAP2 | 6.71e-09 | 1139 | 167 | 23 | 36417873 | |
| Pubmed | Cdx2 regulates endo-lysosomal function and epithelial cell polarity. | 1.11e-08 | 33 | 167 | 6 | 20551175 | |
| Pubmed | MYH10 CALM1 CALM2 CALM3 DSP RPS2 BCLAF1 RPS4X TRIOBP DDX5 MYH14 SERPINC1 | 1.80e-08 | 289 | 167 | 12 | 37132043 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RALA RBM15 MYH10 YBX1 DSP RPS2 BCLAF1 RPS4X YBX3 UPF3B GLOD4 TARS2 PDIA3 DDX5 NUP205 GLMN SBNO1 SMC3 MYH14 SUPT5H ENAH CPSF1 DDX41 CTSD SDHA | 2.24e-08 | 1425 | 167 | 25 | 30948266 |
| Pubmed | RALA MYH10 MYH11 MYO5B DSP RPS2 BCLAF1 RPS4X CNTNAP1 SRPK2 NBEA UPF3B PDIA3 DDX5 MYH14 KBTBD11 MACF1 PLCL1 ATP1B1 FERMT2 DNAH6 UTRN SDHA KLC1 AGAP2 | 2.44e-08 | 1431 | 167 | 25 | 37142655 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CBLL1 RBM15 MYH10 YBX1 DSP RPS2 BCLAF1 RPS4X TRIOBP YTHDC1 TRRAP DDX5 NUP205 TXNL1 SPCS3 SUPT5H CPSF1 MACF1 GPC2 DDX41 TNXB | 6.29e-08 | 1082 | 167 | 21 | 38697112 |
| Pubmed | MYH10 CALM1 CENPE CALM3 YBX1 RPS2 RPS4X YBX3 DDX5 FBN1 EFEMP1 | 9.06e-08 | 271 | 167 | 11 | 26816005 | |
| Pubmed | FBXW10B HECW1 CALM1 CALM2 CALM3 BCLAF1 RPS4X MAGOHB SRPK2 TARS2 PDIA3 DDX5 MMP24 ATP2C2 ENTPD2 PLCL1 MMP15 | 9.84e-08 | 730 | 167 | 17 | 34857952 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 29932249 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 18370588 | ||
| Pubmed | Structural organization of the human CaMIII calmodulin gene. | 1.09e-07 | 3 | 167 | 3 | 2223880 | |
| Pubmed | Molecular mechanisms of calmodulin's functional versatility. | 1.09e-07 | 3 | 167 | 3 | 9923700 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 9681195 | ||
| Pubmed | Allosteric mechanism of water-channel gating by Ca2+-calmodulin. | 1.09e-07 | 3 | 167 | 3 | 23893133 | |
| Pubmed | Expression of HIV-1 envelope glycoprotein alters cellular calmodulin. | 1.09e-07 | 3 | 167 | 3 | 8573130 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 10899953 | ||
| Pubmed | Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. | 1.09e-07 | 3 | 167 | 3 | 9278050 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 15719022 | ||
| Pubmed | Nef of HIV-1 interacts directly with calcium-bound calmodulin. | 1.09e-07 | 3 | 167 | 3 | 11847276 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 10416864 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 7828884 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 8862395 | ||
| Pubmed | Calmodulin is required for cell-cycle progression during G1 and mitosis. | 1.09e-07 | 3 | 167 | 3 | 2469574 | |
| Pubmed | Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. | 1.09e-07 | 3 | 167 | 3 | 15632291 | |
| Pubmed | Blocking the Ca2+-induced conformational transitions in calmodulin with disulfide bonds. | 1.09e-07 | 3 | 167 | 3 | 8631777 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 18553937 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 14978283 | ||
| Pubmed | Calmodulin and HIV type 1: interactions with Gag and Gag products. | 1.09e-07 | 3 | 167 | 3 | 11054265 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 33191766 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 18940602 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 25268113 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 19651602 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 26969752 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 8314583 | ||
| Pubmed | Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. | 1.09e-07 | 3 | 167 | 3 | 11807546 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 8312049 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 37380439 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 16954378 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 31628181 | ||
| Pubmed | Sequence homology of the 3'-untranslated region of calmodulin III in mammals. | 1.09e-07 | 3 | 167 | 3 | 11710561 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 2445749 | ||
| Pubmed | Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin. | 1.09e-07 | 3 | 167 | 3 | 9362478 | |
| Pubmed | The abundance of calmodulin mRNAs is regulated in phosphorylase kinase-deficient skeletal muscle. | 1.09e-07 | 3 | 167 | 3 | 3384819 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 21799007 | ||
| Pubmed | Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure. | 1.09e-07 | 3 | 167 | 3 | 20956522 | |
| Pubmed | Noncanonical binding of calmodulin to aquaporin-0: implications for channel regulation. | 1.09e-07 | 3 | 167 | 3 | 18786401 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 11072229 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 16229872 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 15063758 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 8226798 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 9658102 | ||
| Pubmed | The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. | 1.09e-07 | 3 | 167 | 3 | 17582331 | |
| Pubmed | RBM15 YBX1 DSP RPS2 BCLAF1 RPS4X MAGOHB APOA1 PDIA3 DDX5 NUP205 SMC3 MYH14 CPSF1 SERPINC1 CTSD | 1.18e-07 | 652 | 167 | 16 | 31180492 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RALA RBM15 MYO5B YBX1 DSP RPS2 BCLAF1 RPS4X TRRAP PDIA3 DDX5 NUP205 SMC3 MYH14 SUPT5H CPSF1 MACF1 ATP1B1 DDX41 UTRN | 1.20e-07 | 1024 | 167 | 20 | 24711643 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RBM15 MYH10 YBX1 DSP RPS2 RPS4X DHX40 YBX3 TRRAP PDIA3 DDX5 NUP205 SMC3 MYH14 HLTF CPSF1 MACF1 TAF2 WDFY3 FERMT2 DDX41 CTSD UTRN | 1.52e-07 | 1353 | 167 | 23 | 29467282 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CBLL1 RALA RBM15 MYH10 MYO5B CALM3 YBX1 DSP RPS2 BCLAF1 RPS4X MAGOHB SRPK2 YBX3 YTHDC1 DDX5 NUP205 SMC3 CPSF1 DDX41 CTSD SDHA | 1.78e-07 | 1257 | 167 | 22 | 36526897 |
| Pubmed | VIL1 RALA RBM15 MYH10 MYH11 YBX1 DSP BCLAF1 MAGOHB SRPK2 APOA1 YBX3 UPF3B PDIA3 NUP205 NGRN HABP4 SPCS3 TKFC MYH14 CPSF1 ATP1B1 DDX41 | 1.92e-07 | 1371 | 167 | 23 | 36244648 | |
| Pubmed | CBLL1 MYH10 HECW1 CALM1 CALM2 CENPE BCLAF1 CNTNAP1 TRIOBP SRPK2 NBEA PTPRD CELSR2 ENAH MACF1 PLCL1 WDFY3 KLC1 AGAP2 | 2.18e-07 | 963 | 167 | 19 | 28671696 | |
| Pubmed | 2.20e-07 | 234 | 167 | 10 | 36243803 | ||
| Pubmed | 3.37e-07 | 245 | 167 | 10 | 35652658 | ||
| Pubmed | VIL1 RBM15 YBX1 DSP RPS2 BCLAF1 RPS4X PDIA3 DDX5 NUP205 TKFC MYH14 TOMM34 MACF1 UTRN SDHA | 3.77e-07 | 711 | 167 | 16 | 33022573 | |
| Pubmed | RBM15 MYH10 CALM1 YBX1 RPS2 BCLAF1 RPS4X MAGOHB SRPK2 YBX3 UPF3B TARS2 YTHDC1 DDX5 CPSF1 DDX41 | 3.91e-07 | 713 | 167 | 16 | 29802200 | |
| Pubmed | 3.99e-07 | 191 | 167 | 9 | 33762435 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | VIL1 MYH10 CALM1 CALM2 CALM3 YBX1 DSP RPS2 BCLAF1 RPS4X TWNK SRPK2 PDIA3 DDX5 MYH14 | 4.04e-07 | 626 | 167 | 15 | 33644029 |
| Pubmed | A calmodulin-binding sequence in the C-terminus of human cardiac titin kinase. | 4.33e-07 | 4 | 167 | 3 | 7607248 | |
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 27516456 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 30842726 | ||
| Pubmed | Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. | 4.33e-07 | 4 | 167 | 3 | 23040497 | |
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 16299511 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 15817490 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 25437912 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 17046994 | ||
| Pubmed | A network of control mediated by regulator of calcium/calmodulin-dependent signaling. | 4.33e-07 | 4 | 167 | 3 | 15499021 | |
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 10692436 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 16478480 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 21167176 | ||
| Pubmed | Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6. | 4.33e-07 | 4 | 167 | 3 | 16127172 | |
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 20226167 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 10823944 | ||
| Pubmed | Calm1 signaling pathway is essential for the migration of mouse precerebellar neurons. | 4.33e-07 | 4 | 167 | 3 | 25519244 | |
| Pubmed | Endogenous calmodulin interacts with the epidermal growth factor receptor in living cells. | 4.33e-07 | 4 | 167 | 3 | 14960328 | |
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 22405011 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 11736632 | ||
| Pubmed | Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures. | 4.33e-07 | 4 | 167 | 3 | 29724949 | |
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 20614234 | ||
| Pubmed | A calcium sensor in the sodium channel modulates cardiac excitability. | 4.33e-07 | 4 | 167 | 3 | 11807557 | |
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 11286509 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 20953164 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 19855925 | ||
| Pubmed | Calmodulin binding to the Fas death domain. Regulation by Fas activation. | 4.33e-07 | 4 | 167 | 3 | 14594800 | |
| Pubmed | Structure of calmodulin bound to the hydrophobic IQ domain of the cardiac Ca(v)1.2 calcium channel. | 4.33e-07 | 4 | 167 | 3 | 16338416 | |
| Pubmed | Role of calmodulin in HIV-potentiated Fas-mediated apoptosis. | 4.33e-07 | 4 | 167 | 3 | 8780394 | |
| Interaction | DDX39B interactions | RBM15 MYH10 CALM1 DSP RPS2 BCLAF1 RPS4X MAGOHB SRPK2 APOA1 UPF3B LCT YTHDC1 PDIA3 DDX5 TXNL1 MYH14 SUPT5H CTSD ZRANB1 | 4.71e-08 | 570 | 165 | 20 | int:DDX39B |
| Interaction | RALA interactions | 1.80e-07 | 136 | 165 | 10 | int:RALA | |
| Interaction | CIT interactions | RBM15 ERBB4 MYH10 MYH11 CALM1 YBX1 DSP RPS2 BCLAF1 RPS4X MAGI3 UPF3B MAU2 ADGRV1 TRRAP PNPLA5 DDX5 NUP205 EFEMP1 CELSR2 SMC3 MYH14 SUPT5H HLTF SCO1 CPSF1 MACF1 ATP1B1 FERMT2 MMP15 DDX41 SDHA | 2.23e-07 | 1450 | 165 | 32 | int:CIT |
| Interaction | AURKB interactions | MYH10 MYH11 CALM1 YBX1 DSP RPS2 BCLAF1 RPS4X YBX3 ADGRV1 TRRAP PNPLA5 DDX5 NUP205 MYH14 MYO1F SCO1 MACF1 UTRN ZRANB1 SDHA | 1.14e-06 | 761 | 165 | 21 | int:AURKB |
| Interaction | H2BC4 interactions | RALB MYH10 MYH11 CENPE DHX40 UPF3B PDIA3 FSIP2 SBNO1 SMC3 CPSF1 SDHA | 1.56e-06 | 259 | 165 | 12 | int:H2BC4 |
| Interaction | CCDC8 interactions | RALA CALM1 CALM2 MYO5B CALM3 YBX1 DSP RPS2 RPS4X PDIA3 DDX5 NUP205 SMC3 MYH14 MACF1 ATP1B1 UTRN CDH5 ZRANB1 | 1.90e-06 | 656 | 165 | 19 | int:CCDC8 |
| Interaction | USP7 interactions | MRC1 RBM15 HECW1 CENPE DSP BCLAF1 RPS4X DHX40 YBX3 UPF3B TEX15 ARMCX2 TRRAP DDX5 TXNL1 FBN1 MYO1F KBTBD11 HLTF SCO1 MACF1 KLHDC7A MBD4 GPAT2 UTRN ZRANB1 GSG1 KLC1 | 2.81e-06 | 1313 | 165 | 28 | int:USP7 |
| Interaction | RLIM interactions | MYH10 CALM1 CALM2 CALM3 DSP RPS2 BCLAF1 RPS4X TRIOBP UPF3B DDX5 MYH14 SERPINC1 ZRANB1 | 4.45e-06 | 392 | 165 | 14 | int:RLIM |
| Interaction | ZNF280A interactions | 7.30e-06 | 16 | 165 | 4 | int:ZNF280A | |
| Interaction | FGD5 interactions | 8.24e-06 | 207 | 165 | 10 | int:FGD5 | |
| Interaction | CDK9 interactions | VIL1 MYH10 CALM1 YBX1 RPS2 RPS4X SRPK2 YBX3 TRRAP DDX5 NUP205 SMC3 MYH14 SUPT5H HLTF CPSF1 TAF2 ZRANB1 | 1.36e-05 | 685 | 165 | 18 | int:CDK9 |
| Interaction | PRC1 interactions | RBM15 MYH10 CALM1 CENPE YBX1 DSP RPS2 BCLAF1 RPS4X MAGOHB TWNK YBX3 GLOD4 YTHDC1 TRRAP PDIA3 DDX5 NUP205 YBX2 MYO1F HLTF ZRANB1 | 1.52e-05 | 973 | 165 | 22 | int:PRC1 |
| Interaction | PRP4K interactions | RPS2 BCLAF1 DHX40 MAGOHB SRPK2 YTHDC1 DDX5 HABP4 CPSF1 TAF2 DDX41 ZRANB1 | 1.78e-05 | 329 | 165 | 12 | int:PRP4K |
| Interaction | SPATA17 interactions | 1.84e-05 | 7 | 165 | 3 | int:SPATA17 | |
| Interaction | CUL7 interactions | RALA RBM15 CALM1 CALM2 CALM3 YBX1 DSP RPS2 BCLAF1 RPS4X APOA1 PDIA3 DDX5 NUP205 GLMN SMC3 SUPT5H CPSF1 MACF1 ZRANB1 | 2.01e-05 | 845 | 165 | 20 | int:CUL7 |
| Interaction | PHKA2 interactions | 2.15e-05 | 69 | 165 | 6 | int:PHKA2 | |
| Interaction | KCTD13 interactions | ZMYND19 RALA MYH10 MYH11 MYO5B DSP RPS2 BCLAF1 RPS4X CNTNAP1 TWNK SRPK2 NBEA UPF3B PDIA3 DDX5 MYH14 KBTBD11 MACF1 PLCL1 ATP1B1 FERMT2 DNAH6 UTRN SDHA KLC1 AGAP2 | 2.47e-05 | 1394 | 165 | 27 | int:KCTD13 |
| Interaction | IQSEC2 interactions | 2.90e-05 | 44 | 165 | 5 | int:IQSEC2 | |
| Interaction | KCNN1 interactions | 2.93e-05 | 8 | 165 | 3 | int:KCNN1 | |
| Interaction | ARPP21 interactions | 2.93e-05 | 8 | 165 | 3 | int:ARPP21 | |
| Interaction | MRPL12 interactions | CALM2 CALM3 YBX1 RPS2 EFEMP2 YBX3 PDIA3 NGRN SMC3 SCO1 ZRANB1 VAV1 | 3.09e-05 | 348 | 165 | 12 | int:MRPL12 |
| Interaction | ZC3H18 interactions | CBLL1 RBM15 MYH10 YBX1 DSP RPS2 NEIL1 BCLAF1 DHX40 MAGOHB TWNK SRPK2 YBX3 YTHDC1 DDX5 SMC3 SUPT5H CPSF1 DDX41 ZRANB1 | 3.41e-05 | 877 | 165 | 20 | int:ZC3H18 |
| Interaction | FMR1 interactions | CBLL1 YBX1 BCLAF1 RPS4X MAGI3 SRPK2 NBEA TRRAP DDX5 HABP4 MACF1 WDFY3 ZRANB1 KLC1 AGAP2 | 3.62e-05 | 536 | 165 | 15 | int:FMR1 |
| Interaction | ECT2 interactions | MYH10 MYH11 CALM1 MYO5B YBX1 DSP RPS2 BCLAF1 RPS4X SRPK2 YBX3 TRRAP PNPLA5 DDX5 YBX2 MYH14 MYO1F MACF1 TAF2 ZRANB1 | 3.99e-05 | 887 | 165 | 20 | int:ECT2 |
| Interaction | WDR77 interactions | ZMYND19 MYH10 RPS2 RPS4X TRIOBP MAU2 TRRAP DDX5 SUPT5H TAF2 DDX41 ZRANB1 | 4.41e-05 | 361 | 165 | 12 | int:WDR77 |
| Interaction | EED interactions | RBM15 MYH10 MYH11 CALM1 MYO5B YBX1 DSP RPS2 BCLAF1 RPS4X MAGOHB SRPK2 CUBN TARS2 TRRAP DDX5 NUP205 TXNL1 GLMN SMC3 SUPT5H CPSF1 MACF1 FERMT2 DDX41 ZRANB1 VAV1 | 4.60e-05 | 1445 | 165 | 27 | int:EED |
| Interaction | MECP2 interactions | CBLL1 RBM15 MYH10 YBX1 DSP RPS2 BCLAF1 RPS4X RPP40 TRIOBP TWNK YTHDC1 TRRAP DDX5 NUP205 TXNL1 SPCS3 SMC3 SUPT5H CPSF1 MACF1 GPC2 DDX41 ZRANB1 TNXB | 4.89e-05 | 1287 | 165 | 25 | int:MECP2 |
| Interaction | KIF20A interactions | ENTPD7 MYH10 MYH11 CALM1 CENPE YBX1 DSP RPS2 BCLAF1 RPS4X YBX3 TRRAP PNPLA5 DDX5 NUP205 MYH14 MYO1F HLTF CPSF1 MACF1 MBD4 UTRN | 4.96e-05 | 1052 | 165 | 22 | int:KIF20A |
| Interaction | OBSL1 interactions | RBM15 CALM1 CALM3 YBX1 DSP RPS2 BCLAF1 RPS4X PFKFB4 YTHDC1 TRRAP PDIA3 DDX5 NUP205 SMC3 SUPT5H CPSF1 MACF1 DDX41 UTRN | 5.04e-05 | 902 | 165 | 20 | int:OBSL1 |
| Interaction | IQCG interactions | 6.20e-05 | 10 | 165 | 3 | int:IQCG | |
| Interaction | EIF4A3 interactions | MYH10 YBX1 RPS2 CCDC174 MAGOHB SRPK2 YBX3 UPF3B YTHDC1 DDX5 SUPT5H DDX41 ZRANB1 SDHA | 6.46e-05 | 499 | 165 | 14 | int:EIF4A3 |
| Interaction | H19 interactions | 6.56e-05 | 27 | 165 | 4 | int:H19 | |
| Interaction | PPEF1 interactions | 6.59e-05 | 52 | 165 | 5 | int:PPEF1 | |
| Interaction | HDAC6 interactions | RALA RALB ERBB4 MYH10 MYH11 MYO5B CALM3 YBX1 DSP RPS2 RPS4X CNTNAP1 TRRAP PDIA3 DDX5 MYH14 MYO1F CPSF1 DDX41 ZRANB1 | 7.57e-05 | 929 | 165 | 20 | int:HDAC6 |
| Interaction | CMTR1 interactions | 8.01e-05 | 218 | 165 | 9 | int:CMTR1 | |
| Interaction | PPEF2 interactions | 8.77e-05 | 29 | 165 | 4 | int:PPEF2 | |
| Interaction | DYRK2 interactions | 9.17e-05 | 173 | 165 | 8 | int:DYRK2 | |
| Interaction | UBR4 interactions | CALM1 CALM2 CALM3 RPS2 RPS4X SRPK2 SBNO1 SUPT5H UHMK1 SCO1 ZRANB1 | 1.00e-04 | 334 | 165 | 11 | int:UBR4 |
| Interaction | ESCO1 interactions | 1.01e-04 | 30 | 165 | 4 | int:ESCO1 | |
| Interaction | ACE2 interactions | RBM15 MYH10 CALM1 CALM2 YBX1 DSP RPS2 BCLAF1 RPS4X PDZK1 TRIOBP MAGOHB NBEA YBX3 SLC39A10 TARS2 YTHDC1 PDIA3 DDX5 NUP205 PTPRD SDHA | 1.03e-04 | 1106 | 165 | 22 | int:ACE2 |
| Interaction | PIH1D1 interactions | CALM1 YBX1 DSP RPS2 RPS4X YBX3 GLOD4 PPEF2 PDIA3 DDX5 TXNL1 ENAH CTH DDX41 CTSD ZRANB1 SDHA | 1.08e-04 | 731 | 165 | 17 | int:PIH1D1 |
| Interaction | KIF23 interactions | MYH10 MYH11 CALM1 MYO5B CALM3 YBX1 DSP RPS2 BCLAF1 RPS4X MAGOHB YBX3 PNPLA5 PDIA3 DDX5 MYH14 MYO1F CPSF1 MACF1 DDX41 SDHA | 1.08e-04 | 1031 | 165 | 21 | int:KIF23 |
| Interaction | CPSF6 interactions | ZMYND19 CBLL1 RBM15 BCLAF1 DHX40 MAGOHB SRPK2 YTHDC1 TRRAP DDX5 CHUK SUPT5H CPSF1 ZRANB1 | 1.13e-04 | 526 | 165 | 14 | int:CPSF6 |
| Interaction | UBR5 interactions | CALM1 DSP RPS2 DHX40 MAGOHB TARS2 PPEF1 TRRAP SUPT5H UHMK1 CPSF1 TAF2 DDX41 ZRANB1 | 1.29e-04 | 533 | 165 | 14 | int:UBR5 |
| Interaction | SH2B1 interactions | 1.30e-04 | 32 | 165 | 4 | int:SH2B1 | |
| Interaction | C11orf65 interactions | 1.45e-04 | 13 | 165 | 3 | int:C11orf65 | |
| Interaction | TNIP1 interactions | RBM15 MYH10 MYH11 CALM1 YBX1 DSP RPS2 BCLAF1 RPS4X YBX3 UPF3B YTHDC1 DDX5 GLMN EFEMP1 SMC3 MYH14 CPSF1 HAPLN3 TAF2 DDX41 CTSD SDHA | 1.52e-04 | 1217 | 165 | 23 | int:TNIP1 |
| Interaction | RPL31 interactions | YBX1 RPS2 BCLAF1 RPS4X SRPK2 YBX3 UPF3B YTHDC1 DDX5 NGRN TXNL1 YBX2 SUPT5H MACF1 DDX41 ZRANB1 | 1.52e-04 | 680 | 165 | 16 | int:RPL31 |
| Interaction | NSMF interactions | 1.86e-04 | 35 | 165 | 4 | int:NSMF | |
| Interaction | GOLGA8A interactions | 1.86e-04 | 35 | 165 | 4 | int:GOLGA8A | |
| Interaction | TRPC4AP interactions | 2.04e-04 | 103 | 165 | 6 | int:TRPC4AP | |
| Interaction | DHX40 interactions | 2.18e-04 | 249 | 165 | 9 | int:DHX40 | |
| Interaction | CAMKK2 interactions | 2.55e-04 | 69 | 165 | 5 | int:CAMKK2 | |
| Interaction | KHDRBS1 interactions | CBLL1 RBM15 DUSP1 SRPK2 YTHDC1 TRRAP DDX5 SH3YL1 EFEMP1 ZRANB1 VAV1 | 2.61e-04 | 373 | 165 | 11 | int:KHDRBS1 |
| Interaction | SRSF6 interactions | YBX1 RPS2 BCLAF1 RPS4X TWNK SRPK2 YBX3 YTHDC1 TRRAP NGRN YBX2 ZRANB1 VAV1 | 2.64e-04 | 503 | 165 | 13 | int:SRSF6 |
| Interaction | AKR7L interactions | 3.11e-04 | 72 | 165 | 5 | int:AKR7L | |
| Interaction | EFTUD2 interactions | RALB MYH10 CALM1 YBX1 DSP RPS2 RPS4X RPP40 MAGOHB SRPK2 YBX3 UPF3B GLOD4 PPEF1 PDIA3 DDX5 TXNL1 SBNO1 SMC3 SUPT5H HLTF SCO1 MACF1 CTH ZRANB1 | 3.12e-04 | 1449 | 165 | 25 | int:EFTUD2 |
| Interaction | CHMP4B interactions | MYH10 MYH11 CALM1 DSP RPS2 BCLAF1 RPS4X DDX5 TXNL1 SMC3 MYH14 MYO1F TAF2 DDX41 ZRANB1 SDHA | 3.22e-04 | 727 | 165 | 16 | int:CHMP4B |
| Interaction | CNTNAP2 interactions | 3.29e-04 | 158 | 165 | 7 | int:CNTNAP2 | |
| Interaction | H2BC12 interactions | 3.32e-04 | 322 | 165 | 10 | int:H2BC12 | |
| Interaction | MAGOH interactions | 3.36e-04 | 264 | 165 | 9 | int:MAGOH | |
| Interaction | LAG3 interactions | 3.37e-04 | 17 | 165 | 3 | int:LAG3 | |
| Interaction | MYO9B interactions | 3.37e-04 | 113 | 165 | 6 | int:MYO9B | |
| Interaction | NRCAM interactions | 3.46e-04 | 41 | 165 | 4 | int:NRCAM | |
| Interaction | ARHGAP19 interactions | 3.54e-04 | 74 | 165 | 5 | int:ARHGAP19 | |
| Interaction | MRPL17 interactions | 3.55e-04 | 160 | 165 | 7 | int:MRPL17 | |
| Interaction | TMOD1 interactions | 3.68e-04 | 161 | 165 | 7 | int:TMOD1 | |
| Interaction | IQGAP1 interactions | MYH10 CALM1 CALM2 MYO5B CALM3 YBX1 BCLAF1 RPS4X TRIOBP DDX5 SMC3 ZRANB1 KLC1 AGAP2 | 3.72e-04 | 591 | 165 | 14 | int:IQGAP1 |
| Cytoband | 4q34.2 | 7.85e-05 | 4 | 167 | 2 | 4q34.2 | |
| GeneFamily | Y box binding proteins | 2.64e-07 | 3 | 117 | 3 | 106 | |
| GeneFamily | Myosin heavy chains | 1.14e-04 | 15 | 117 | 3 | 1098 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 2.47e-04 | 4 | 117 | 2 | 1244 | |
| GeneFamily | EF-hand domain containing | 5.59e-04 | 219 | 117 | 7 | 863 | |
| GeneFamily | RAS type GTPase family | 1.04e-03 | 31 | 117 | 3 | 389 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.13e-03 | 8 | 117 | 2 | 939 | |
| GeneFamily | Fibulins | 1.13e-03 | 8 | 117 | 2 | 556 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.45e-03 | 9 | 117 | 2 | 1230 | |
| GeneFamily | Doublecortin superfamily | 1.81e-03 | 10 | 117 | 2 | 1369 | |
| GeneFamily | DNA glycosylases | 2.20e-03 | 11 | 117 | 2 | 1024 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 3.09e-03 | 13 | 117 | 2 | 693 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_STROMAL_CELL_AGEING | CALM1 CALM2 CALM3 DUSP1 TRIOBP PDIA3 DDX5 FBN1 ENTPD2 CST4 PCOLCE2 TNXB | 2.66e-06 | 349 | 167 | 12 | MM3790 |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN | ERBB4 MYH10 MYH11 CALM1 DSP PDZK1 GLOD4 ARMCX2 SH3YL1 PTPRD KBTBD11 HLTF TOMM34 CTH SDHA | 2.80e-06 | 553 | 167 | 15 | M1475 |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 2.94e-06 | 184 | 167 | 9 | M9005 | |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | VIL1 DCDC2 ERBB4 PDZK1 PGM2L1 NBEA ZNF229 ARMCX2 YTHDC1 EFEMP1 CELSR2 PLPP1 UCP2 ATP2C2 ENAH MACF1 ATP1B1 UTRN | 3.00e-06 | 786 | 167 | 18 | M10961 |
| Coexpression | GSE12366_GC_VS_MEMORY_BCELL_DN | 5.13e-06 | 197 | 167 | 9 | M3173 | |
| Coexpression | LAKE_ADULT_KIDNEY_C18_COLLECTING_DUCT_PRINCIPAL_CELLS_MEDULLA | DCDC2 MYH10 CALM1 YBX1 DSP RPS2 RPS4X DUSP1 PDIA3 DDX5 ATP1B1 | 7.47e-06 | 322 | 167 | 11 | M39237 |
| Coexpression | AIZARANI_LIVER_C7_EPCAM_POS_BILE_DUCT_CELLS_2 | 1.20e-05 | 219 | 167 | 9 | M39111 | |
| Coexpression | JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN | 1.36e-05 | 48 | 167 | 5 | MM529 | |
| Coexpression | MCCLUNG_DELTA_FOSB_TARGETS_8WK | 1.83e-05 | 51 | 167 | 5 | MM647 | |
| Coexpression | BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP | FBXW10B RBM15 CYP26B1 MYO5B DUSP1 FBXL14 CUBN SCN1A SERPINC1 TNXB | 2.35e-05 | 299 | 167 | 10 | M34002 |
| Coexpression | BAELDE_DIABETIC_NEPHROPATHY_DN | UBR2 ERBB4 CALM2 DUSP1 YBX3 GLOD4 ARMCX2 PDIA3 PTPRD KBTBD11 TOMM34 FERMT2 | 2.54e-05 | 437 | 167 | 12 | M4665 |
| Coexpression | GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP | 3.89e-05 | 196 | 167 | 8 | M4928 | |
| Coexpression | GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_UP | 3.89e-05 | 196 | 167 | 8 | M7389 | |
| Coexpression | GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_UP | 4.03e-05 | 197 | 167 | 8 | M4434 | |
| Coexpression | BROWNE_HCMV_INFECTION_30MIN_DN | 4.15e-05 | 145 | 167 | 7 | M0 | |
| Coexpression | WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN | 4.49e-05 | 200 | 167 | 8 | M10091 | |
| Coexpression | GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP | 4.49e-05 | 200 | 167 | 8 | M5668 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | RALA CALM1 CALM2 CALM3 RPS4X DUSP1 DDX5 CELSR2 KLHDC8A UCP2 MACF1 | 4.79e-05 | 394 | 167 | 11 | MM3724 |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | RALA RALB DCDC2 CALM2 MYO5B DUSP1 HGSNAT TRIOBP MAGI3 PGM2L1 YBX3 SH3YL1 MYH14 LACC1 ENAH MACF1 ATP1B1 CTSD MYRF UTRN SDHA | 6.54e-05 | 1276 | 167 | 21 | M39173 |
| Coexpression | LIU_PROSTATE_CANCER_DN | MYH11 EFEMP2 LPCAT4 CACHD1 TXNL1 UBA7 FBN1 EFEMP1 CELSR2 ENAH PLCL1 FERMT2 | 8.09e-05 | 493 | 167 | 12 | M19391 |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_LUMINAL_EPITHELIAL_CELL_OF_MAMMARY_GLAND_AGEING | 9.21e-05 | 352 | 167 | 10 | MM3788 | |
| Coexpression | MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN | 9.92e-05 | 224 | 167 | 8 | M38981 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | UBR2 RALB BCLAF1 UPF3B GLOD4 YTHDC1 SMC3 HLTF MACF1 WDFY3 MBD4 | 1.02e-04 | 429 | 167 | 11 | M29 |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | MYH11 DUSP1 ARMCX2 SPCS3 PTPRD PLPP1 ENAH MACF1 FERMT2 CDH5 TNXB | 1.38e-04 | 444 | 167 | 11 | MM1051 |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_LOOP_OF_HENLE_THICK_ASCENDING_LIMB_EPITHELIAL_CELL_AGEING | 1.51e-04 | 238 | 167 | 8 | MM3728 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 1.56e-04 | 179 | 167 | 7 | MM660 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 1.62e-04 | 80 | 167 | 5 | MM1285 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP | 1.62e-04 | 17 | 167 | 3 | MM686 | |
| Coexpression | MENON_FETAL_KIDNEY_2_NEPHRON_PROGENITOR_CELLS | 1.77e-04 | 44 | 167 | 4 | M39252 | |
| Coexpression | AIZARANI_LIVER_C24_EPCAM_POS_BILE_DUCT_CELLS_3 | 1.91e-04 | 185 | 167 | 7 | M39125 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_DN | 2.39e-04 | 192 | 167 | 7 | M9983 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | CALM1 YBX1 RPS2 BCLAF1 RPS4X DUSP1 DDX5 SPCS3 SBNO1 UCP2 UHMK1 MYO1F MACF1 UTRN VAV1 KLC1 | 2.48e-04 | 911 | 167 | 16 | M40038 |
| Coexpression | DING_LUNG_CANCER_BY_MUTATION_RATE | 2.67e-04 | 20 | 167 | 3 | M1189 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_UP | 2.71e-04 | 196 | 167 | 7 | M7718 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN | 2.80e-04 | 197 | 167 | 7 | M7921 | |
| Coexpression | GSE3982_NKCELL_VS_TH2_UP | 2.80e-04 | 197 | 167 | 7 | M5596 | |
| Coexpression | GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_DN | 2.98e-04 | 199 | 167 | 7 | M7326 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_DN | 3.07e-04 | 200 | 167 | 7 | M8027 | |
| Coexpression | GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP | 3.07e-04 | 200 | 167 | 7 | M3271 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_DN | 3.07e-04 | 200 | 167 | 7 | M4569 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_DN | 3.07e-04 | 200 | 167 | 7 | M9842 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_DN | 3.07e-04 | 200 | 167 | 7 | M3929 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_UP | 3.07e-04 | 200 | 167 | 7 | M8850 | |
| Coexpression | GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_UP | 3.07e-04 | 200 | 167 | 7 | M6424 | |
| Coexpression | GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN | 3.07e-04 | 200 | 167 | 7 | M6556 | |
| ToppCell | PSB-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.42e-09 | 199 | 167 | 10 | 58dcb0eedafa8629585dc99e53147e2287f49689 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.38e-08 | 184 | 167 | 9 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.54e-08 | 185 | 167 | 9 | 0c247a3f394c42e2a6f67fee3d9cf33096fecd13 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.88e-08 | 187 | 167 | 9 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.87e-08 | 192 | 167 | 9 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.09e-08 | 193 | 167 | 9 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | Mesenchymal_cells-Endosteal_fibro.|Mesenchymal_cells / Lineage and Cell class | 5.32e-08 | 194 | 167 | 9 | 9a4b5de4d1d8a0aa76fed7b36548ea628f3009cc | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 6.62e-08 | 199 | 167 | 9 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.62e-08 | 199 | 167 | 9 | e03bdc7cb825e287f41b834ec6061d23c1c03b04 | |
| ToppCell | Bronchial_Biopsy-Epithelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.62e-08 | 199 | 167 | 9 | ef5d8917c8d011184830a0b8197afc6266707b37 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.91e-08 | 200 | 167 | 9 | c89f3cb36bb14c476d6a392bfd3ded1c8feecfeb | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 6.91e-08 | 200 | 167 | 9 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.91e-08 | 200 | 167 | 9 | 68b0f987c4fb8078675475f4f1e71302f832ef69 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 6.91e-08 | 200 | 167 | 9 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 6.91e-08 | 200 | 167 | 9 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.96e-07 | 179 | 167 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.31e-07 | 181 | 167 | 8 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.50e-07 | 182 | 167 | 8 | cc79e0cc21e2fdc4ef77f052818d27b9f707aec1 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-07 | 184 | 167 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.89e-07 | 184 | 167 | 8 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-07 | 184 | 167 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-07 | 184 | 167 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 5.09e-07 | 185 | 167 | 8 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.30e-07 | 186 | 167 | 8 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.52e-07 | 187 | 167 | 8 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 6.23e-07 | 190 | 167 | 8 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 6.48e-07 | 191 | 167 | 8 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | PND07|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.74e-07 | 192 | 167 | 8 | 8171a60df481195c39a7f740effcae8e4deb6ca7 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.01e-07 | 193 | 167 | 8 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.01e-07 | 193 | 167 | 8 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | ASK440-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.88e-07 | 196 | 167 | 8 | 833723c8753922374cd7730907f1596899dd5734 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.18e-07 | 197 | 167 | 8 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Immature_Interneurons|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.50e-07 | 198 | 167 | 8 | 5798640425cabf4ac517b7f96a9dfd32f6e5e7c5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.50e-07 | 198 | 167 | 8 | ff6d9455ebfe965cc6f48197172c0ebd3bddde81 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.50e-07 | 198 | 167 | 8 | 5375a2895cf995f0db4a61861093f01794707901 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.50e-07 | 198 | 167 | 8 | f006d68e6c51923be7772eea118546a5762e8a5e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.50e-07 | 198 | 167 | 8 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.50e-07 | 198 | 167 | 8 | 5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-07 | 199 | 167 | 8 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal-Neurons|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 8.83e-07 | 199 | 167 | 8 | 0c5a5fbb174a013be10961f0db65c65c797ab4af | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-07 | 199 | 167 | 8 | 7223f853335492ca617dbec3e4b6872a8a463a45 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.83e-07 | 199 | 167 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.83e-07 | 199 | 167 | 8 | a4ebb0598e9a0c9f6e39a0db6d0623654c2a7d88 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.83e-07 | 199 | 167 | 8 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.83e-07 | 199 | 167 | 8 | 5059a1d4df7d9989c922007a8dcba98b1f5687d5 | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.17e-07 | 200 | 167 | 8 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.17e-07 | 200 | 167 | 8 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Duct|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.17e-07 | 200 | 167 | 8 | 1b527bebbca1ef8c52449e40beb9358e37494e04 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 9.17e-07 | 200 | 167 | 8 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 9.17e-07 | 200 | 167 | 8 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 9.17e-07 | 200 | 167 | 8 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.17e-07 | 200 | 167 | 8 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.17e-07 | 200 | 167 | 8 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-06 | 145 | 167 | 7 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 3.42e-06 | 168 | 167 | 7 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-06 | 169 | 167 | 7 | 4ac21e8199de4b6917eacadc56fffc6d886ee643 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.70e-06 | 170 | 167 | 7 | d682178d11d67eb5a02d0c6b3967645e37bcc62a | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.85e-06 | 171 | 167 | 7 | 1af575809b3334bfaa019ff26c56e6cb03c82ee8 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.31e-06 | 174 | 167 | 7 | 2cd6638b361ca05ab83d09ce657194aed97873b7 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.31e-06 | 174 | 167 | 7 | edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.31e-06 | 174 | 167 | 7 | 65539f69100db0b7d90b1b39ee15ab8281f86461 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.48e-06 | 175 | 167 | 7 | 35fb7735dd3355476fe60404833cb60bd066bcf1 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.48e-06 | 175 | 167 | 7 | 442f261a3b2c4d2523f7d4089178f8c79cac2f0f | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_Interneurons|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.65e-06 | 176 | 167 | 7 | 62870115e31170c8b42eec57c709e0fe32388b37 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-06 | 177 | 167 | 7 | 66ffa279147961080c104242a08b176e301d80e3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-06 | 177 | 167 | 7 | 227d4f423b00be2e0c5797e2c5275d342e69a0f4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-06 | 177 | 167 | 7 | 0cbf54608d2ba0a0500af142f2029fe5e118c3c2 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.01e-06 | 178 | 167 | 7 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-06 | 179 | 167 | 7 | 88dbec952507d84b85b08165eec80df99ed1e736 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-06 | 179 | 167 | 7 | daf8189a22786171e2b629261cf720736aa4ebdb | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.20e-06 | 179 | 167 | 7 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.39e-06 | 180 | 167 | 7 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | P28-Mesenchymal|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.80e-06 | 182 | 167 | 7 | 69f9d44694fe4f55a971ae0ac5dc3e7448ee78f3 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.01e-06 | 183 | 167 | 7 | 06ac66726ec53db810ebb90ec69cfdb903da53f6 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.23e-06 | 184 | 167 | 7 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | droplet-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.23e-06 | 184 | 167 | 7 | e02859bbac36dbbd55d7ae8cb5e46b764d7c6381 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.45e-06 | 185 | 167 | 7 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.45e-06 | 185 | 167 | 7 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.68e-06 | 186 | 167 | 7 | e0a2ea4b46af742bc7c9b2072bb85e27d5c92712 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.68e-06 | 186 | 167 | 7 | 88e6246172d816806a498a5c1f38e699f2f5d7c2 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.92e-06 | 187 | 167 | 7 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.92e-06 | 187 | 167 | 7 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.92e-06 | 187 | 167 | 7 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | P15-Mesenchymal|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.17e-06 | 188 | 167 | 7 | f1ba0b661621a65c91432e62ba73531bdf18e7c1 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.17e-06 | 188 | 167 | 7 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Monocyte-derived_DC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.17e-06 | 188 | 167 | 7 | 08eb1e4b719af53c52895557523d0a1b7421d849 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.17e-06 | 188 | 167 | 7 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 7.17e-06 | 188 | 167 | 7 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 7.42e-06 | 189 | 167 | 7 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.42e-06 | 189 | 167 | 7 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.42e-06 | 189 | 167 | 7 | e76dc36a01d8ad7590b3acc4c46abfcb76857448 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.68e-06 | 190 | 167 | 7 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-06 | 190 | 167 | 7 | 3720e64129f3f3268b1dc14031a76f41c38241c2 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-06 | 190 | 167 | 7 | 73a50426f972f08f9bb525ad5c0b774187ab5d6a | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-06 | 190 | 167 | 7 | b55cf1fb586b724295b7b038483249847bb344fc | |
| ToppCell | droplet-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.68e-06 | 190 | 167 | 7 | 0b7200897b2c389632c9b1ee37e272b811555dbc | |
| ToppCell | droplet-Mammary_Gland-nan-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-06 | 191 | 167 | 7 | 8022059e434fd411dc539819f969bd4f94861281 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.95e-06 | 191 | 167 | 7 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.95e-06 | 191 | 167 | 7 | cd497abed9e00e4e0becd9dbc036c6e7a60ae791 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.95e-06 | 191 | 167 | 7 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| Drug | purealin | 2.21e-07 | 58 | 167 | 7 | CID006419303 | |
| Drug | NSC366363 | 3.88e-07 | 3 | 167 | 3 | CID000339501 | |
| Drug | AC1NDS53 | 3.88e-07 | 3 | 167 | 3 | CID004630710 | |
| Drug | tatsiensine | 3.88e-07 | 3 | 167 | 3 | CID000163526 | |
| Drug | delcosine | 3.88e-07 | 3 | 167 | 3 | CID000120726 | |
| Drug | Kr I | 5.67e-07 | 10 | 167 | 4 | CID005288675 | |
| Drug | IQ-3 | 8.85e-07 | 11 | 167 | 4 | CID000028212 | |
| Drug | Nsc642900 | 1.54e-06 | 4 | 167 | 3 | CID000498959 | |
| Drug | CTK0F9956 | 1.54e-06 | 4 | 167 | 3 | CID011779542 | |
| Drug | 85318-25-8 | 1.54e-06 | 4 | 167 | 3 | CID006439702 | |
| Drug | cloxacepride | 1.54e-06 | 4 | 167 | 3 | CID000068859 | |
| Drug | chloraniformethan | 1.54e-06 | 4 | 167 | 3 | CID000030331 | |
| Drug | Ti 233 | 1.54e-06 | 4 | 167 | 3 | CID000173248 | |
| Drug | diisopropylphosphoramidite | 1.54e-06 | 4 | 167 | 3 | CID000080867 | |
| Drug | herbarumin III | 1.54e-06 | 4 | 167 | 3 | CID000643678 | |
| Drug | thiomethylpromazine | 1.54e-06 | 4 | 167 | 3 | CID000070583 | |
| Drug | KS-504e | 1.54e-06 | 4 | 167 | 3 | CID000129559 | |
| Drug | KS-504d | 1.54e-06 | 4 | 167 | 3 | CID000129557 | |
| Drug | Archanagelicine | 1.54e-06 | 4 | 167 | 3 | CID003083773 | |
| Drug | N,N-dimethyladriamycin-14-valerate | 1.54e-06 | 4 | 167 | 3 | CID000127194 | |
| Drug | Roylin | 1.54e-06 | 4 | 167 | 3 | CID000099924 | |
| Drug | KS-502 | 1.54e-06 | 4 | 167 | 3 | CID000129242 | |
| Drug | KS-501 | 1.54e-06 | 4 | 167 | 3 | CID000129240 | |
| Drug | 2'-methoxykobusin | 1.54e-06 | 4 | 167 | 3 | CID000637889 | |
| Drug | PS-990 | 1.54e-06 | 4 | 167 | 3 | CID000157810 | |
| Drug | pyrophosphate | ENTPD7 MYH10 MYH11 CALM1 CALM2 MYO5B CALM3 PFKFB4 TARS2 SPCS3 TKFC PLPP1 MYH14 DHPS ALG3 ACP4 WDFY3 SDHA | 1.61e-06 | 654 | 167 | 18 | CID000001023 |
| Drug | sulfamide | 2.91e-06 | 31 | 167 | 5 | CID000082267 | |
| Drug | jujubogenin | 3.83e-06 | 5 | 167 | 3 | CID005318721 | |
| Drug | D 890 | 3.83e-06 | 5 | 167 | 3 | CID000134083 | |
| Drug | NSC-36360 | 3.83e-06 | 5 | 167 | 3 | CID000133340 | |
| Drug | alpha-CAO | 3.83e-06 | 5 | 167 | 3 | CID000196600 | |
| Drug | AC1NS8P3 | 3.83e-06 | 5 | 167 | 3 | CID005356151 | |
| Drug | 4H-1,4-benzothiazin-3-one | 3.83e-06 | 5 | 167 | 3 | CID000021396 | |
| Drug | Y-acid | 3.83e-06 | 5 | 167 | 3 | CID000007022 | |
| Drug | C16AA | 3.83e-06 | 5 | 167 | 3 | CID000488017 | |
| Drug | auranthine | 3.83e-06 | 5 | 167 | 3 | CID000130919 | |
| Drug | Ant-ATP | 3.83e-06 | 5 | 167 | 3 | CID000134953 | |
| Drug | Nor2 chlorpromazine | 3.83e-06 | 5 | 167 | 3 | CID000074981 | |
| Drug | Fsh-beta-(1-15) | 3.83e-06 | 5 | 167 | 3 | CID005748474 | |
| Drug | Ac-dvda | 3.83e-06 | 5 | 167 | 3 | CID000146768 | |
| Drug | VUF 4576 | 3.83e-06 | 5 | 167 | 3 | CID000132784 | |
| Drug | AC1MHK15 | 6.17e-06 | 17 | 167 | 4 | CID003052795 | |
| Drug | 1,6-di-o-phosphonohexopyranose | 7.50e-06 | 64 | 167 | 6 | CID000000737 | |
| Drug | AC1NSV6X | 7.63e-06 | 6 | 167 | 3 | CID005317173 | |
| Drug | N-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide | 7.63e-06 | 6 | 167 | 3 | CID000004307 | |
| Drug | 2,5-diketocamphane | 7.63e-06 | 6 | 167 | 3 | CID000020218 | |
| Drug | benziodarone | 7.63e-06 | 6 | 167 | 3 | CID000006237 | |
| Drug | AC1LCMSV | 7.63e-06 | 6 | 167 | 3 | CID000633347 | |
| Drug | CI-922 | 7.63e-06 | 6 | 167 | 3 | CID000146938 | |
| Drug | caged PE | 7.63e-06 | 6 | 167 | 3 | CID000192405 | |
| Drug | propyl-methylenedioxyindene | 7.63e-06 | 6 | 167 | 3 | CID000145934 | |
| Drug | 4pal | 1.23e-05 | 20 | 167 | 4 | CID005748175 | |
| Drug | 1-(4-pyridyl)ethanol | 1.33e-05 | 7 | 167 | 3 | CID000090919 | |
| Drug | AC1L52O2 | 1.33e-05 | 7 | 167 | 3 | CID000196983 | |
| Drug | chloronitromethane | 1.33e-05 | 7 | 167 | 3 | CID000074529 | |
| Drug | trifluoperazine sulfoxide | 1.33e-05 | 7 | 167 | 3 | CID000159622 | |
| Drug | DyCl3 | 1.33e-05 | 7 | 167 | 3 | CID000066207 | |
| Drug | DAPpNP | 1.33e-05 | 7 | 167 | 3 | CID005492375 | |
| Drug | T 7188 | 1.33e-05 | 7 | 167 | 3 | CID000003311 | |
| Drug | MS-857 | 1.33e-05 | 7 | 167 | 3 | CID000129517 | |
| Drug | SQ 65442 | 1.33e-05 | 7 | 167 | 3 | CID000128039 | |
| Drug | AC1L3PE4 | 1.33e-05 | 7 | 167 | 3 | CID000093048 | |
| Drug | O-4-(ethoxybutyl)berbamine | 1.33e-05 | 7 | 167 | 3 | CID000188375 | |
| Drug | TZC-5665 | 1.33e-05 | 7 | 167 | 3 | CID006449836 | |
| Drug | KHL-8430 | 1.33e-05 | 7 | 167 | 3 | CID000195711 | |
| Drug | CPU57 | 1.33e-05 | 7 | 167 | 3 | CID000195730 | |
| Drug | Drnflrfamide | 1.33e-05 | 7 | 167 | 3 | CID000132879 | |
| Drug | 4-hydroxyphenylglycol | 1.33e-05 | 7 | 167 | 3 | CID003081980 | |
| Drug | asocainol | 1.33e-05 | 7 | 167 | 3 | CID000071161 | |
| Drug | p-nitrophenyl phosphate | 1.38e-05 | 194 | 167 | 9 | CID000000378 | |
| Drug | proxyl nitroxide | 2.11e-05 | 8 | 167 | 3 | CID000076702 | |
| Drug | niludipine | 2.11e-05 | 8 | 167 | 3 | CID000089767 | |
| Drug | Ro 22-4839 | 2.11e-05 | 8 | 167 | 3 | CID000065839 | |
| Drug | HT-74 | 2.11e-05 | 8 | 167 | 3 | CID000126681 | |
| Drug | 2,6-ANS | 2.11e-05 | 8 | 167 | 3 | CID002762570 | |
| Drug | AC1MJ4D0 | 2.11e-05 | 8 | 167 | 3 | CID003085362 | |
| Drug | 3,7,8-trihydroxy-CPZ | 2.11e-05 | 8 | 167 | 3 | CID000467415 | |
| Drug | KS-504a | 2.11e-05 | 8 | 167 | 3 | CID000129577 | |
| Drug | NSP-805 | 2.11e-05 | 8 | 167 | 3 | CID000130349 | |
| Drug | triphenylethylene | 2.15e-05 | 46 | 167 | 5 | CID000006025 | |
| Drug | AC1L25Y6 | 2.22e-05 | 23 | 167 | 4 | CID000015465 | |
| Drug | lanthanum chloride hydrate | 2.22e-05 | 23 | 167 | 4 | CID000165791 | |
| Drug | gamma-cyhalothrin | 2.39e-05 | 47 | 167 | 5 | CID000443046 | |
| Drug | phenyldiazene | 3.13e-05 | 25 | 167 | 4 | CID000141902 | |
| Drug | cyhexatin | 3.13e-05 | 25 | 167 | 4 | CID005364545 | |
| Drug | w66 | 3.15e-05 | 9 | 167 | 3 | CID006439460 | |
| Drug | 7,8-diOH-CPZ | 3.15e-05 | 9 | 167 | 3 | CID000159916 | |
| Drug | adamantanone | 3.15e-05 | 9 | 167 | 3 | CID000064151 | |
| Drug | picumast | 3.15e-05 | 9 | 167 | 3 | CID000431850 | |
| Drug | 5-exo-hydroxycamphor | 3.15e-05 | 9 | 167 | 3 | CID000440017 | |
| Drug | KS-505a | 3.15e-05 | 9 | 167 | 3 | CID003081782 | |
| Drug | adenosylcobalamin | 4.32e-05 | 53 | 167 | 5 | CID000424379 | |
| Drug | 1-isoamyl-3-isobutylxanthine | 4.48e-05 | 10 | 167 | 3 | CID000152034 | |
| Drug | norchlorpromazine | 4.48e-05 | 10 | 167 | 3 | CID000062875 | |
| Drug | AC1L8MM4 | 4.48e-05 | 10 | 167 | 3 | CID000429016 | |
| Drug | sulfonamide | 4.73e-05 | 54 | 167 | 5 | CID000005333 | |
| Drug | ytterbium | 5.17e-05 | 55 | 167 | 5 | CID000023992 | |
| Drug | indolidan | 6.12e-05 | 11 | 167 | 3 | CID005284402 | |
| Drug | 4-iodotamoxifen | 6.12e-05 | 11 | 167 | 3 | CID003037006 | |
| Drug | alpha-amyrin linoleate | 6.12e-05 | 11 | 167 | 3 | CID005318324 | |
| Disease | Hyperinsulinism | 1.58e-05 | 28 | 161 | 4 | C0020459 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 1.86e-05 | 10 | 161 | 3 | C1631597 | |
| Disease | Malignant neoplasm of breast | ERBB4 YBX1 RPS4X PDZK1 MAGOHB PFKFB4 CUBN EFEMP1 PTPRD SBNO1 CST4 TENM1 MACF1 GPC2 KLHDC7A CDH5 AGAP2 | 8.54e-05 | 1074 | 161 | 17 | C0006142 |
| Disease | aortic aneurysm (is_implicated_in) | 8.84e-05 | 3 | 161 | 2 | DOID:3627 (is_implicated_in) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.03e-04 | 53 | 161 | 4 | C4707243 | |
| Disease | Endogenous Hyperinsulinism | 3.78e-04 | 26 | 161 | 3 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 3.78e-04 | 26 | 161 | 3 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 3.78e-04 | 26 | 161 | 3 | C1257965 | |
| Disease | loneliness measurement | 6.07e-04 | 124 | 161 | 5 | EFO_0007865 | |
| Disease | Phencyclidine-Related Disorders | 6.10e-04 | 7 | 161 | 2 | C0236742 | |
| Disease | Phencyclidine Abuse | 6.10e-04 | 7 | 161 | 2 | C0031391 | |
| Disease | Hypoxemia | 7.71e-04 | 33 | 161 | 3 | C0700292 | |
| Disease | Hypoxia | 7.71e-04 | 33 | 161 | 3 | C0242184 | |
| Disease | Anoxemia | 7.71e-04 | 33 | 161 | 3 | C0003129 | |
| Disease | Anoxia | 7.71e-04 | 33 | 161 | 3 | C0003130 | |
| Disease | level of Phosphatidylinositol (16:0_20:4) in blood serum | 8.11e-04 | 8 | 161 | 2 | OBA_2045154 | |
| Disease | Global developmental delay | 8.33e-04 | 133 | 161 | 5 | C0557874 | |
| Disease | Nonsyndromic Deafness | 1.02e-03 | 81 | 161 | 4 | C3711374 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.04e-03 | 9 | 161 | 2 | C3502809 | |
| Disease | post-traumatic stress disorder symptom measurement | 1.07e-03 | 82 | 161 | 4 | EFO_0008535 | |
| Disease | personality trait | 1.26e-03 | 39 | 161 | 3 | EFO_0004365 | |
| Disease | Hereditary hearing loss and deafness | 1.26e-03 | 146 | 161 | 5 | cv:C0236038 | |
| Disease | Cannabis Abuse | 1.29e-03 | 10 | 161 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 1.29e-03 | 10 | 161 | 2 | C0236735 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.29e-03 | 10 | 161 | 2 | cv:C4707243 | |
| Disease | Hashish Abuse | 1.29e-03 | 10 | 161 | 2 | C0018614 | |
| Disease | abdominal obesity-metabolic syndrome (implicated_via_orthology) | 1.29e-03 | 10 | 161 | 2 | DOID:0060611 (implicated_via_orthology) | |
| Disease | osteoarthritis | 1.42e-03 | 222 | 161 | 6 | MONDO_0005178 | |
| Disease | Secondary Biliary Cholangitis | 1.57e-03 | 42 | 161 | 3 | C0238065 | |
| Disease | Biliary cirrhosis | 1.57e-03 | 42 | 161 | 3 | C0023892 | |
| Disease | Biliary Cirrhosis, Primary, 1 | 1.57e-03 | 42 | 161 | 3 | C4551595 | |
| Disease | triacylglycerol 56:6 measurement | 1.68e-03 | 43 | 161 | 3 | EFO_0010433 | |
| Disease | Dental enamel hypoplasia | 1.88e-03 | 12 | 161 | 2 | EFO_1001304 | |
| Disease | intraocular pressure measurement | 2.00e-03 | 509 | 161 | 9 | EFO_0004695 | |
| Disease | Primary biliary cirrhosis | 2.17e-03 | 47 | 161 | 3 | C0008312 | |
| Disease | Hamman-Rich syndrome | 2.58e-03 | 14 | 161 | 2 | C0085786 | |
| Disease | phosphatidate measurement | 2.97e-03 | 15 | 161 | 2 | EFO_0020047 | |
| Disease | cathepsin D measurement | 2.97e-03 | 15 | 161 | 2 | EFO_0010611 | |
| Disease | response to cisplatin, platinum measurement | 3.06e-03 | 53 | 161 | 3 | EFO_0010154, GO_0072718 | |
| Disease | creatinine measurement | VIL1 DCDC2 TPCN2 DHX40 NR1H3 ADGRV1 CUBN SH3YL1 GLMN MMP24 CELSR2 KLHDC7A MBD4 | 3.27e-03 | 995 | 161 | 13 | EFO_0004518 |
| Disease | cervical carcinoma | 3.30e-03 | 182 | 161 | 5 | EFO_0001061 | |
| Disease | Romano-Ward Syndrome | 3.38e-03 | 16 | 161 | 2 | C0035828 | |
| Disease | osteosarcoma (is_implicated_in) | 3.38e-03 | 16 | 161 | 2 | DOID:3347 (is_implicated_in) | |
| Disease | Schizophrenia | DDR1 DCDC2 ERBB4 MYO5B PDZK1 CSMD2 TRRAP SBNO1 UCP2 UHMK1 TNXB SDHA | 3.42e-03 | 883 | 161 | 12 | C0036341 |
| Disease | optic cup area measurement | 3.58e-03 | 56 | 161 | 3 | EFO_0006940 | |
| Disease | Cannabis Dependence | 3.81e-03 | 17 | 161 | 2 | C0006870 | |
| Disease | partial epilepsy | 3.81e-03 | 17 | 161 | 2 | EFO_0004263 | |
| Disease | major depressive disorder (is_marker_for) | 3.81e-03 | 17 | 161 | 2 | DOID:1470 (is_marker_for) | |
| Disease | X-21441 measurement | 3.81e-03 | 17 | 161 | 2 | EFO_0800814 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 4.27e-03 | 18 | 161 | 2 | OBA_2045155 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 4.42e-03 | 121 | 161 | 4 | EFO_0004612, EFO_0005271 | |
| Disease | serum gamma-glutamyl transferase measurement | ENTPD7 TRIOBP TWNK FCRLA CSMD3 SH3YL1 CELSR2 SBNO1 ENAH KLHDC7A MMP15 KLC1 | 4.50e-03 | 914 | 161 | 12 | EFO_0004532 |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 4.76e-03 | 19 | 161 | 2 | EFO_0004612, EFO_0008589 | |
| Disease | Usual Interstitial Pneumonia | 4.76e-03 | 19 | 161 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 4.76e-03 | 19 | 161 | 2 | C4721508 | |
| Disease | anorectal malformation | 4.76e-03 | 19 | 161 | 2 | MONDO_0019938 | |
| Disease | level of Phosphatidylethanolamine (18:0_20:4) in blood serum | 4.76e-03 | 19 | 161 | 2 | OBA_2045140 | |
| Disease | type 1 diabetes mellitus (biomarker_via_orthology) | 4.76e-03 | 19 | 161 | 2 | DOID:9744 (biomarker_via_orthology) | |
| Disease | response to methotrexate, neurotoxicity | 4.76e-03 | 19 | 161 | 2 | EFO_0011057, GO_0031427 | |
| Disease | transitional cell carcinoma (is_marker_for) | 4.98e-03 | 63 | 161 | 3 | DOID:2671 (is_marker_for) | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 4.98e-03 | 63 | 161 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | docosahexaenoic acid measurement | 5.25e-03 | 127 | 161 | 4 | EFO_0007761 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 5.27e-03 | 20 | 161 | 2 | C4721952 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALAIFLNYRKDGNFG | 116 | Q15303 | |
| ENIGYSEKDRFQGRF | 281 | P05026 | |
| FGRDVNFTLDGYVQR | 271 | P78357 | |
| GYVQRFILNGDFERL | 281 | P78357 | |
| GLRLGNDFRYNKTVT | 2961 | Q7Z408 | |
| NAGLYGNFRAQLRFI | 1146 | Q7Z407 | |
| IREAFRVFDKDGNGY | 86 | P0DP25 | |
| GYLSRSFDLGRQFLF | 256 | Q92685 | |
| NAGEFFRDQGRQVYL | 856 | Q08345 | |
| GVDFYSELRNKGFQR | 316 | Q2KHT4 | |
| SAVYDVVRNRGNFGD | 911 | Q8WXG9 | |
| FLRDLAEQNSGKYGV | 396 | Q5VU97 | |
| GTNRYFRQVASEFGL | 116 | P32929 | |
| DAQGRTALFYARQAG | 1121 | Q99490 | |
| RDYVSQFEGSALGKQ | 51 | P02647 | |
| DRDSGLNGRVFYTFQ | 841 | Q9HCU4 | |
| QEGKFRYRRVAEGTQ | 286 | P01008 | |
| IREAFRVFDKDGNGY | 86 | P0DP24 | |
| GYSIRRTSDKGQFFR | 406 | P33151 | |
| GQFFRVTKKGDIYNE | 416 | P33151 | |
| LRAEVFNYREFNKGS | 581 | Q7L311 | |
| EGKGIFYNIKNFVRF | 721 | O75185 | |
| FATYDERRNGQLGSV | 146 | P30301 | |
| GDFETFENLRQRGYQ | 1356 | Q9HC84 | |
| AAIRDNYFRSGEGFL | 76 | P11233 | |
| AAIRDNYFRSGEGFL | 76 | P11234 | |
| FGFQIGVRYENKKRE | 956 | Q96T37 | |
| RFGGSDRLRQFKFQD | 1721 | Q92621 | |
| EGQNYGFFLRIEKDT | 16 | Q5T2W1 | |
| YNREDFAKAGLQVEF | 321 | Q13133 | |
| ACADGKIRIYNFFNG | 631 | O95170 | |
| RLTFKNGRVYEGAFS | 321 | P0C881 | |
| RLTFKNGRVYEGAFS | 321 | B2RC85 | |
| AAYERADGRFVFFKG | 431 | Q9Y5R2 | |
| YEALQGFQFRVGASD | 521 | Q9Y5F0 | |
| DVFLRKQESGFGFRV | 726 | Q5TCQ9 | |
| SFGDYQGRVHLRQDK | 111 | Q96S86 | |
| FGYFQQDTKGLVDFR | 376 | Q643R3 | |
| LDQRFFNGIGNYLRA | 166 | Q96FI4 | |
| RGREFFDSNGNFLYR | 276 | Q9NPE2 | |
| GGNFARQRYEDLVLN | 316 | Q9NQZ7 | |
| FKVGNRFQTARFYRD | 11 | Q9HC38 | |
| FNGLFSRLRDFYGES | 141 | Q8N158 | |
| LSENFLDYKNRGVNG | 121 | Q76N89 | |
| GLKEDYSRLFQGQRA | 436 | O15111 | |
| GFQSSRREKYGNVFK | 71 | Q9NR63 | |
| AAYERQDGRFVFFKG | 421 | P51511 | |
| RYSAGKRGGFNTFRD | 496 | P17844 | |
| KRGGFNTFRDRENYD | 501 | P17844 | |
| FNGEDIGKNTFKYRG | 311 | Q5CZC0 | |
| GFLYFNRQGELRISV | 986 | Q10570 | |
| IRKNQAIDFQFGREY | 586 | Q9P1W3 | |
| DAFDQRGKREFERYG | 206 | Q5JVS0 | |
| QQLLSRGYGFDERAF | 406 | Q9Y5L3 | |
| RFGKFIRINFDVAGY | 261 | Q7Z406 | |
| NLYRVGQSKIFFRAG | 776 | Q7Z406 | |
| FKQRGFVVGYDTRGQ | 106 | Q6PCE3 | |
| ERRATIFNFGEQNGY | 136 | Q16877 | |
| IGENKYRFGDSQQLR | 3271 | O94854 | |
| RLANAAGFNVEKFYR | 231 | Q8IV20 | |
| SEKRRINGTYDFFGF | 1666 | P09848 | |
| AYRRGYFINNKQDGE | 266 | Q9BX67 | |
| RYLQVSKNRFDGDVG | 601 | Q96RR1 | |
| FNGGEVNDARRIGKY | 216 | Q9UKZ9 | |
| GDIRTIFSYFKGQRQ | 356 | Q9UJV9 | |
| REYYFNGGSNRKVRE | 261 | Q495T6 | |
| IFGYLDVRDKGRAAQ | 16 | Q8N1E6 | |
| YDCKGGELFANQRRF | 71 | Q75N03 | |
| KDGGNVTVSLFYRND | 326 | Q9BZG2 | |
| RDRFDGYVFLDNKGQ | 111 | Q9BZI7 | |
| TDEGQQGRGFKAEYR | 1261 | O60494 | |
| ELLRQYQDFGGFYDR | 2181 | Q9C0G6 | |
| GGQYSNAEDIFRKAL | 351 | Q13325 | |
| REARAAQVFFLKGGY | 111 | P28562 | |
| YDLGDTGRIGRNNFK | 516 | Q5THR3 | |
| LKNRGQYVAAGFERF | 71 | A2VCK2 | |
| LFSFYKDGRIVQSRG | 206 | Q7L513 | |
| NRYLIESGNEDGFFK | 2791 | P35555 | |
| FNRGVNYRALLEAFG | 36 | P49366 | |
| GNRESDGFREEKNYK | 446 | Q9NYF8 | |
| GRYYTVFDRDNNRVG | 391 | P07339 | |
| VGRDRVQFGALKYSD | 846 | A8TX70 | |
| KGLVDRKFFDQYRSG | 2536 | P15924 | |
| DFGEADGRYFRLSQQ | 666 | Q6NUI2 | |
| GNRKEAARIAAEFYG | 46 | Q8WWX0 | |
| QRLFGKTAGRFDVYF | 96 | O95243 | |
| NGFLYRFDLNRSLGI | 676 | Q5VTJ3 | |
| GGRQSKYAVNAFEVF | 181 | Q8IYD2 | |
| RFGEFGNYSLLVKNI | 156 | Q68CP4 | |
| IREAFRVFDKDGNGY | 86 | P0DP23 | |
| NEARQLGVGYFAFAR | 241 | Q6PII3 | |
| RDARQVYGLNFGSKE | 81 | Q8N8S7 | |
| VKNEGRATIGRYFNE | 681 | Q14527 | |
| GGYIFLSTRAKDQNE | 651 | Q96AC1 | |
| FQIRAGNSQGDFYIR | 376 | O95967 | |
| LRAREQTFGGVNYFF | 71 | P01036 | |
| GYFKNVARRSVGRTF | 626 | Q8IX18 | |
| GEFLDYFGQNKRKGE | 271 | O75880 | |
| KLFERYGENGRLSFF | 66 | Q9ULF5 | |
| GLFSFFQGRYNEAKR | 466 | Q9Y6X3 | |
| DLSRFNFDNKYGRNA | 1031 | A3KN83 | |
| KLSDGQVGGFINYRD | 271 | Q02224 | |
| LENGQFYVAVGRDKF | 201 | Q9UHG0 | |
| RFGKFIRINFDVTGY | 241 | P35580 | |
| GALYRRQGKFEAAET | 471 | Q07866 | |
| RSYVFNGDFVDRGKD | 201 | O14830 | |
| DHLGQRKQYGGDFLR | 126 | Q8N323 | |
| YVFRLSARNKVGFGE | 891 | P23468 | |
| YVFNGDFVDRGKNSI | 196 | O14829 | |
| KGEDLFFNYGNRQEK | 111 | P22897 | |
| FRKGGEHLYNFVIFN | 331 | O75818 | |
| FRIKSGNENGEFYLR | 426 | Q12805 | |
| FKEEDFGLFQLAGQR | 21 | Q92990 | |
| FEFRPDGKLRYANNS | 26 | Q96A72 | |
| KRFIGDYERNAGNLY | 56 | Q9BPW5 | |
| RFDLQYKGQAGALER | 566 | Q9BW92 | |
| GFLEYSGLNRQFLFR | 4106 | O75445 | |
| QRGFDSFLGRYQAVQ | 876 | P46939 | |
| ENGYINFDKRRKEFA | 451 | O15211 | |
| GVAERQQKLRSQYFF | 581 | Q8IYR2 | |
| ERTDLYAKQGRGSQF | 371 | Q9UQE7 | |
| SRTEDGKIYQRAFGG | 161 | P31040 | |
| FYGSFAFNRKRNVLE | 531 | Q6P1X5 | |
| GKALERFLQDYFDGN | 346 | P30101 | |
| FRGERYIDGALSNNL | 161 | Q7Z6Z6 | |
| YERGRFSNFSINGKL | 2841 | Q8NFP9 | |
| GEKRADIQLNSFGFY | 41 | Q9NPR9 | |
| NAERVKEGRLSFYSG | 156 | O14494 | |
| NYDRAVEAFAKGGNL | 106 | Q96HL8 | |
| KYFFFDDGNGLKGNR | 126 | P61009 | |
| RYVDVSGRTEQFGKF | 2066 | Q9UKZ4 | |
| GFLRQRGNDIFEYNS | 2216 | Q9UKZ4 | |
| GENFRLIYDTKGRFA | 96 | P62701 | |
| GDFLIFEGNRYSRKG | 356 | O00267 | |
| FIYRFDLSGSRGEAQ | 501 | O94819 | |
| FGQERRKSEAAGAFQ | 1311 | Q9H2D6 | |
| GGLFIASNRQRLDEY | 151 | Q9UL12 | |
| RKGFRFSIEGNRLTY | 531 | P35498 | |
| RFGKFIRINFDVTGY | 241 | P35749 | |
| GRQKGFLAIDGFTQY | 366 | Q15111 | |
| ELRAAGNESFRNGQY | 11 | Q15785 | |
| GNESEAFRGYFKQGL | 101 | P09327 | |
| GYGFINRNDTKEDVF | 106 | Q9Y2T7 | |
| GNGAKIFAYAFDKNR | 46 | Q96E35 | |
| IFAYAFDKNRGRGSG | 51 | Q96E35 | |
| NAYKTIAREEGFRGL | 161 | P55851 | |
| RNGYGFINRNDTKED | 101 | P16989 | |
| VFSGDGRNYLLAFQK | 2631 | Q8IZQ1 | |
| GYGFINRNDTKEDVF | 71 | P67809 | |
| VFGAGFQEKLRRQHY | 421 | P41226 | |
| LGKNNEFSRLVAGEY | 336 | Q9BQI7 | |
| DQGAQGYELFFKTRE | 476 | P15498 | |
| SGKYSREFFNRRGEL | 616 | P78362 | |
| GQFDSFVVQYKDRDG | 1801 | P22105 | |
| GRFDSFTVQYKDRDG | 2436 | P22105 | |
| QGRFDSFTVQYKDRD | 2546 | P22105 | |
| QGRFDSFTVQYKDRD | 2976 | P22105 | |
| GRFDSFTVQYKDRDG | 3191 | P22105 | |
| RNFYESKIGRFQGCL | 311 | Q5T7W7 | |
| FSGVRRDVFLNGSYN | 576 | Q96MU7 | |
| GENGLKSNEYRNGFR | 261 | Q9UJW7 | |
| IRENTYRCKEFGNAF | 196 | Q86V71 | |
| NFQRDLAKGGTVEYA | 2306 | Q92508 | |
| GFQGRLKYNAFCELQ | 1746 | Q9BXT5 | |
| RTRFKAFVAIGDYNG | 121 | P15880 | |
| YTGDRLNFGLAREQA | 111 | Q3LXA3 | |
| GRFQFERYTALQAFK | 456 | Q8IWV8 | |
| DTGKLNVAYFRFDIN | 3701 | Q9Y4A5 | |
| YGFRKERAALEQLQG | 71 | Q8TAS1 | |
| KSFRGETLGYTRFQG | 546 | Q9UGI0 | |
| GKQDDGQDRERLTYF | 241 | Q8NHX9 | |
| FFRNKVRIDQYQGAD | 81 | O43396 | |
| QKEFDRVTLGYTQGF | 86 | P22310 | |
| SRFGKYFEIQFSRGG | 166 | O00160 | |
| FGRTKIFFRAGQVAY | 741 | Q9ULV0 | |
| NYNSSRFGEGVEREL | 396 | Q6NSJ0 | |
| TYRVDADKGFNFSVG | 376 | Q9Y2G1 |